[go: up one dir, main page]

WO2019187377A1 - Base material for filler, manufacturing method of base material for filler, filler, and protein purification method - Google Patents

Base material for filler, manufacturing method of base material for filler, filler, and protein purification method Download PDF

Info

Publication number
WO2019187377A1
WO2019187377A1 PCT/JP2018/045660 JP2018045660W WO2019187377A1 WO 2019187377 A1 WO2019187377 A1 WO 2019187377A1 JP 2018045660 W JP2018045660 W JP 2018045660W WO 2019187377 A1 WO2019187377 A1 WO 2019187377A1
Authority
WO
WIPO (PCT)
Prior art keywords
filler
carrier
base material
polymer
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2018/045660
Other languages
French (fr)
Japanese (ja)
Inventor
直樹 内山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Resonac Holdings Corp
Original Assignee
Showa Denko KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Showa Denko KK filed Critical Showa Denko KK
Publication of WO2019187377A1 publication Critical patent/WO2019187377A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/26Esters containing oxygen in addition to the carboxy oxygen
    • C08F220/32Esters containing oxygen in addition to the carboxy oxygen containing epoxy radicals
    • C08F220/325Esters containing oxygen in addition to the carboxy oxygen containing epoxy radicals containing glycidyl radical, e.g. glycidyl (meth)acrylate
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/10Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/20Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the sorbent material
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • B01J20/24Naturally occurring macromolecular compounds, e.g. humic acids or their derivatives
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/28Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281Sorbents specially adapted for preparative, analytical or investigative chromatography
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/282Porous sorbents
    • B01J20/285Porous sorbents based on polymers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30Processes for preparing, regenerating, or reactivating
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/26Cation exchangers for chromatographic processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • B01J41/20Anion exchangers for chromatographic processes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/20Esters of polyhydric alcohols or phenols, e.g. 2-hydroxyethyl (meth)acrylate or glycerol mono-(meth)acrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • C08F8/08Epoxidation

Definitions

  • the present invention relates to a filler substrate, a method for producing a filler substrate, a filler, and a protein purification method.
  • Chromatographic fillers include inorganic fillers such as silica gel, natural polymer fillers such as agarose, dextran, cellulose, chitosan, and organics such as polystyrene, poly (meth) acrylate, poly (meth) acrylamide, etc.
  • Polymeric fillers are known. These fillers are used as they are or with various interactive functional groups added as necessary in order to enable use in various separation modes.
  • Natural polymer fillers and organic polymer fillers are superior in stability to alkaline solutions used for column cleaning compared to inorganic fillers.
  • the natural polymer filler has insufficient mechanical strength. For this reason, a column packed with a natural polymer filler is difficult to use under high flow rate processing conditions.
  • natural polymer fillers have insufficient mechanical strength, and thus are difficult to use for protein separation and purification on large scale columns.
  • organic polymer fillers such as polystyrene, poly (meth) acrylate, poly (meth) acrylamide and the like are desirable for the column filler used under high flow rate processing conditions.
  • Biopolymers such as proteins have a large molecular weight.
  • a column used under high flow rate processing conditions in order to increase the adsorption capacity of the separation target having a large molecular weight, it is necessary to increase the diffusion efficiency of the separation target into the pores of the carrier used as the filler. .
  • a carrier having a large pore diameter has a small specific surface area, so that it is difficult to obtain a sufficient adsorption capacity for the separation target.
  • the filler having a large pore volume has poor mechanical strength, the performance under a high flow rate treatment condition may not be sufficiently obtained.
  • Patent Document 1 and Non-Patent Document 1 succeed in improving the protein adsorption capacity by using a filler in which an organic polymer is covalently bonded to a base material by graft polymerization.
  • the introduction of the organic polymer to the base material by graft polymerization has a drawback that it is difficult to obtain reproducibility.
  • Patent Document 2 a technique using a polysaccharide such as dextran or pullulan as a spacer is widely known.
  • a technique using a polysaccharide such as dextran or pullulan as a spacer is widely known.
  • Patent Document 2 and Non-Patent Documents 2 to 4 by successfully immobilizing dextran having an average molecular weight of about 40,000 on an agarose carrier and introducing ion exchange groups, the adsorption capacity was successfully improved. Yes.
  • Patent Document 3 the inside of the pore is filled and fixed with a water-soluble linear organic polymer containing a polysaccharide, and an affinity functional group is bound to the water-soluble linear organic polymer site. Fillers that are porous particles are described. Patent Document 3 describes a filler that has a large amount of protein that can be purified at a time because of its high adsorption amount, and can significantly improve the purification rate. Moreover, it is described that the filler of patent document 3 is harder than the conventional filler, and is excellent in durability.
  • Patent Document 4 describes a porous carrier having a porosity of 80% or more and a column pressure loss of 0.02 MPa or more and less than 0.2 MPa.
  • the present invention has been made in view of the above circumstances, and is provided with a filler base material and a filler base material from which a filler having sufficient mechanical strength and a high biopolymer adsorption capacity can be obtained. It is an object to provide a manufacturing method. Another object of the present invention is to provide a filler having a sufficient mechanical strength using the above-mentioned filler base material and having a high biopolymer adsorption capacity, and a protein purification method using the filler. To do.
  • a porous organic polymer carrier having a degree of cross-linking of 50 mol% to 85 mol% has good mechanical strength, and a filler using a base material for filler using the polymer may be a protein or the like. Even if the adsorption capacity of the biopolymer is increased, the mechanical strength can be secured.
  • a porous organic polymer carrier having an exclusion limit molecular weight of 200,000 to 800,000 and a pore volume ratio of 96 volume% to 99 volume% has a size and number of pores in each pore. Is appropriate. For this reason, the filler using the base material for fillers using this becomes a thing with high adsorption capacity of a biopolymer.
  • the ratio of the mass of the group derived from the natural polymer to the mass of the base material for filler is 200 mg / g to 300 mg / g
  • the base material can sufficiently exhibit the effect as a spacer due to the immobilization of the group derived from the natural polymer, and the biopolymer based on the group derived from the natural polymer while ensuring the ratio of the pore volume. The effect of improving the adsorption capacity is sufficiently obtained.
  • a filler in which an interactive functional group is covalently bonded to a filler base material in which a natural polymer is immobilized on the surface of a porous organic polymer carrier of (1) to (3) By selecting the type of the interactive functional group, a filler according to the application can be obtained.
  • the filler of (4) Since the filler of (4) has a high biopolymer adsorption capacity even under high flow rate processing conditions, a large amount of biopolymer such as protein can be purified in a short time.
  • the present inventor polymerizes a raw material monomer containing a monofunctional monomer having an epoxy group and a predetermined amount of a crosslinkable monomer in the presence of a predetermined amount of a diluent and a polymerization initiator by the following method. Then, the epoxy group derived from the monofunctional monomer of the polymer is ring-opened and the epoxy group is introduced using epichlorohydrin and secondary alcohol, and 200 mg / g to 300 mg / g It discovered that said base material for fillers was obtained by fix
  • a filler base material in which a natural polymer is immobilized on the surface of a porous organic polymer carrier has a cross-linking degree of 50 mol% to 85 mol%, an exclusion limit molecular weight of 200,000 to 800,000, and a pore volume ratio of 96 vol% to 99 vol%.
  • the base material of the first aspect of the present invention can preferably include the following features.
  • the second aspect of the present invention provides the filler described in [4] below.
  • the second aspect of the present invention can preferably include the following features. [5] The filler according to [4], wherein the interactive functional group is a cation exchange group. [6] The filler according to [4], wherein the interactive functional group is an anion exchange group.
  • the third aspect of the present invention is a method for producing a filler substrate described in [7] below.
  • the third aspect of the present invention can preferably include the following features.
  • the monofunctional monomer having an epoxy group is glycidyl methacrylate,
  • the crosslinkable monomer is ethylene glycol dimethacrylate;
  • the diluent is chlorobenzene
  • [7] The method for producing a filler base material according to [7], wherein the secondary alcohol is 2-propanol.
  • the fourth aspect of the present invention is a protein purification method described in [11] below.
  • [11] A step of passing a solution containing protein through a column packed with the packing material according to any one of [4] to [6]; And a step of eluting the protein adsorbed on the filler.
  • the filler in which the interactive functional group is covalently bonded to the filler base material of the present invention has sufficient mechanical strength and a high adsorption capacity for biopolymers such as proteins.
  • the filler of the present invention has a large amount of biopolymer that can be purified at one time per unit volume, can contribute to an improvement in purification rate, and can be suitably used under high flow rate treatment conditions.
  • the base material for filler of the present embodiment is one in which a natural polymer is immobilized on the surface of a porous organic polymer carrier.
  • the porous organic polymer carrier has a crosslinking degree of 50 mol% to 85 mol%, an exclusion limit molecular weight of 200,000 to 800,000, and a pore volume ratio of 96 vol% to 99 vol%.
  • the filler base material using the porous organic polymer carrier has a high adsorption capacity for biopolymers such as proteins and sufficient mechanical strength. It will have.
  • the degree of crosslinking of the porous organic polymer carrier is preferably 55 mol% to 70 mol%.
  • the degree of cross-linking of the porous organic polymer carrier is less than 50 mol%, the mechanical strength is insufficient, and a filler including a filler base material using the porous organic polymer carrier cannot be used under high flow rate processing conditions. If the degree of cross-linking of the porous organic polymer carrier is more than 85 mol%, the group derived from the natural polymer is not sufficiently introduced to the surface. Run short.
  • the exclusion limit molecular weight of the porous organic polymer carrier is 200,000 to 800,000, more preferably 300,000 to 500,000.
  • the base material for filler using the porous organic polymer carrier has a high adsorption capacity for biopolymers such as proteins.
  • the exclusion limit molecular weight is 800,000 or less, the filler base material using the molecular weight has sufficient mechanical strength.
  • the ratio of the pore volume of the porous organic polymer carrier (ratio of the volume of the pores to the total volume of the filler) is 96% to 99% by volume.
  • the proportion of the pore volume is 96% by volume or more, the base material for filler using this has a high adsorption capacity for biopolymers such as proteins.
  • the proportion of the pore volume is 99% by volume or less, a filler having sufficient mechanical strength can be obtained from the filler base material using the pore volume.
  • the natural polymer immobilized on the surface of the porous organic polymer carrier is not particularly limited as long as it is soluble in water, and a linear organic polymer having a hydroxyl group and an amino group in the skeleton is preferable.
  • a linear organic polymer having a hydroxyl group and an amino group in the skeleton is preferable.
  • the linear organic polymer for example, a highly hydrophilic polysaccharide having a plurality of hydroxyl groups in the molecule is preferably used.
  • Specific examples of the polysaccharide include agarose, dextran, pullulan, starch, cellulose, and derivatives thereof.
  • dextran is preferably used because of its high water solubility and relatively easy introduction into a porous organic polymer carrier.
  • the weight average molecular weight of the natural polymer is not particularly limited, but is preferably 5,000 to 5,000,000, and more preferably 100,000 to 1,000,000.
  • the weight average molecular weight of the natural polymer is 5,000 or more, the effect of improving the adsorption amount by the group derived from the immobilized natural polymer becomes more remarkable.
  • the molecular weight of the natural polymer is 5,000,000 or less, the group derived from the immobilized natural polymer occupies the majority of the pore internal space of the base material for filler, thereby Thus, it is possible to prevent the room for separation and penetration of the high molecular weight separation object such as the like into the space in the pore.
  • the ratio of the mass of the group derived from the natural polymer to the mass of the base material for filler is 200 mg / g to 300 mg / g, preferably 210 mg / g to 280 mg / g.
  • the mass ratio of the group derived from the natural polymer is 200 mg / g or more, the effect of improving the adsorption capacity of the biopolymer by the group derived from the natural polymer is sufficiently obtained in the filler base material.
  • the mass ratio of the group derived from the natural polymer is 300 mg / g or less, the group derived from the natural polymer immobilized on the filler base material is in the pore space of the porous organic polymer carrier. By occupying the majority, it is possible to prevent a room for high-molecular-weight separation objects such as proteins from diffusing and penetrating into the pore space.
  • Step (A) is a step of obtaining a polymer ⁇ by polymerizing a raw material monomer containing a monofunctional monomer having an epoxy group and a crosslinkable monomer in the presence of a diluent and a polymerization initiator.
  • the concentration of the crosslinkable monomer in the raw material monomer is set to 50 mol% to 85 mol%, and the diluent is used in a volume of 3.8 times to 5.8 times that of the raw material monomer.
  • Step (B) is a step of obtaining a carrier ⁇ made of a porous organic polymer by opening an epoxy group derived from a monofunctional monomer of the polymer ⁇ .
  • Step (C) is a step of obtaining a carrier ⁇ by introducing an epoxy group into the carrier ⁇ using epichlorohydrin and a secondary alcohol.
  • Step (D) is a step of obtaining the base material for filler of the present embodiment (hereinafter sometimes referred to as “carrier ⁇ ”) by immobilizing the natural polymer on the carrier ⁇ .
  • carrier ⁇ the ratio of the mass of the group derived from the natural polymer to the mass of the carrier ⁇ is set to 200 mg / g to 300 mg / g.
  • a raw material monomer containing a monofunctional monomer having an epoxy group and a crosslinkable monomer is polymerized in the presence of a diluent and a polymerization initiator to obtain a polymer ⁇ .
  • the monofunctional monomer having an epoxy group used when synthesizing the polymer ⁇ is a compound having only one ethylenic carbon-carbon double bond (referred to as a polymerizable functional group).
  • the crosslinkable monomer is a compound having a plurality of polymerizable functional groups.
  • the raw material monomer may contain a monofunctional monomer having an epoxy group and another monomer that is not a crosslinkable monomer, if necessary.
  • the monofunctional monomer having an epoxy group is not particularly limited.
  • glycidyl (meth) acrylate, 4,5-epoxypentyl (meth) acrylate, 4- (2,3-epoxypropyl) -n -Epoxy compounds such as butyl (meth) acrylate, 9,10-epoxystearyl acrylate, 4- (2,3-epoxypropyl) cyclohexylmethyl acrylate, allyl glycidyl ether, 3,4-epoxycyclohexylmethyl (meth) acrylate
  • Examples include alicyclic epoxy compounds such as 3,4-epoxycyclohexylethyl (meth) acrylate, 3,4-epoxycyclohexylpropyl (meth) acrylate, and vinylbenzyl glycidyl ether.
  • These monofunctional monomers having an epoxy group may be used alone or in combination of two or more.
  • the monofunctional monomer having an epoxy group preferably includes one or both of glycidyl (meth) acrylate and 3,4-epoxycyclohexylmethyl (meth) acrylate among the above-mentioned compounds. It is preferable to use glycidyl methacrylate because it preferably contains (meth) acrylate and is readily available commercially.
  • the crosslinkable monomer is not particularly limited, and a monomer having a plurality of polymerizable functional groups can be used.
  • the bifunctional monomer include divinyl aromatic compounds such as divinylbenzene, alkylene glycol-di (meth) acrylates such as ethylene glycol di (meth) acrylate and polyethylene glycol di (meth) acrylate, alkylene (carbon number) 1-11) Bis (meth) acrylates, N, N′-methylenebis (meth) acrylamide, N, N′-ethylene-bis (meth) acrylamide, N, N′-hexamethylene-bis (meth) acrylamide, etc.
  • crosslinkable monomer examples include alkylene (having 1 to 11 carbon atoms) bis (meth) acrylamides.
  • examples of the trifunctional monomer include trivinylbenzene and glycerin tri (meth) acrylate.
  • These crosslinkable monomers may be used alone or in combination of two or more.
  • the crosslinkable monomer preferably contains ethylene glycol dimethacrylate, and it is preferable to use ethylene glycol dimethacrylate alone, which can easily form pores having a volume sufficient to adsorb proteins. Most preferred.
  • the mole percentage of the crosslinkable monomer in the raw material monomer is 50 mol% to 85 mol%.
  • a polymer ⁇ having a crosslinking degree of 50 mol% to 85 mol% is obtained, and in the step (D), a filler base material (carrier ⁇ ) having a crosslinking degree of 50 mol% to 85 mol% is obtained.
  • the molar percentage of the crosslinkable monomer in the raw material monomer is preferably 55 mol% to 70 mol% so that a filler base material (carrier ⁇ ) having a crosslinking degree of 55 mol% to 70 mol% can be obtained.
  • a monomer having an unsaturated functional group can be used and is not particularly limited.
  • other monomers include aromatic monomers such as styrene, methylstyrene, ethylstyrene, hydroxystyrene, and chlorostyrene, methyl (meth) acrylate, ethyl (meth) acrylate, hydroxyethyl (meth) acrylate, hydroxypropyl ( (Meth) acrylate, hydroxybutyl (meth) acrylate, hydroxypentyl (meth) acrylate, 2-chloroethyl (meth) acrylate, (meth) acrylates such as polyethylene glycol (meth) acrylate, dimethyl (meth) acrylamide, diethyl (meth) (Meth) acrylamides such as acrylamide, hydroxye
  • a diluent is used when polymerizing a raw material monomer composed of a monofunctional monomer having an epoxy group, a crosslinkable monomer, and other monomers contained as necessary.
  • a porous polymer ⁇ can be obtained.
  • the raw material monomer can be dissolved, and can be uniformly mixed with the raw material monomer and the polymerization initiator under the polymerization reaction conditions.
  • the polymer ⁇ obtained by polymerizing the raw material monomer is not dissolved, and the polymerization reaction is not performed.
  • An active organic solvent can be used. Such an organic solvent varies depending on the type of raw material monomer and can be arbitrarily selected.
  • the diluent examples include aromatic hydrocarbons such as chlorobenzene, toluene, xylene, diethylbenzene and dodecylbenzene, saturated hydrocarbons such as hexane, heptane and decane, alcohols such as isoamyl alcohol, hexyl alcohol and octyl alcohol. Can be used. These diluents may be used alone or in combination of two or more. Among the diluents described above, chlorobenzene is preferably used because a pore size sufficient to adsorb the biopolymer can be obtained.
  • Diluent is used in a volume of 3.8 to 5.8 times the volume of the raw material monomer.
  • the values obtained by measuring the volume (volume) of the raw material monomer as a mixture and the volume (volume) of the diluent, respectively, at room temperature are used. .
  • the exclusion limit molecular weight and the ratio of the pore volume in the polymer ⁇ and the filler base material (carrier ⁇ ) can be changed.
  • volume of the diluent to be used By setting the volume of the diluent to be used to be 3.8 times or more of the volume of the raw material monomer, a porous organic high molecular weight having an exclusion limit molecular weight of 200,000 or more and a pore volume ratio of 96% by volume or more. A polymer ⁇ which is a molecule is obtained.
  • the amount of the diluent used is preferably 4.0 or more times the volume of the raw material monomer in order to further increase the exclusion limit molecular weight and pore volume ratio of the polymer ⁇ .
  • the amount of the diluent used By setting the amount of the diluent used to a volume of 5.8 times or less that of the raw material monomer, it is possible to prevent the hardness of the polymer ⁇ from becoming too low, and a polymer ⁇ having sufficient mechanical strength can be obtained.
  • the amount of the diluent used is preferably 5.0 times or less the volume of the raw material monomer in order to obtain a polymer ⁇ having better mechanical strength.
  • Polymerization initiator As the polymerization initiator used for the polymerization of the raw material monomers, various known radical polymerization initiators such as organic peroxides and azo initiators can be used. Examples of the organic peroxide used as the polymerization initiator include tert-butylperoxyneodecanoate, t-butylperoxy-2-ethylhexanoate, and t-butylperoxyisobutyrate in the case of butyl peroxide.
  • amyl peroxide systems such as rate, 2,5-dimethyl-2,5-di (benzoylperoxy) hexane, t-butylperoxyacetate, t-butylperoxybenzoate, etc., t-amylperoxy-2-ethyl Hexanoate, t-amyl peroxy-n-octoate, t-amyl peroxyacetate, t-amyl peroxybenzoate, etc., in peroxy carbonate type, t-butyl peroxyisopropyl carbonate, t-butyl peroxy-2 -Ethylhexyl carbonate, t-amyl peroxy
  • dialkyl peroxides such as -2-ethylhexyl carbonate, di (2-ethylhexyl) peroxydicarbonate, di (sec-butyl) peroxydicarbonate, dicumyl peroxide, 2,5-dimethyl
  • azo initiator used as the polymerization initiator examples include 2,2′-azobis (4-methoxy-2,4-dimethylvaleronitrile) and 2,2′-azobis (2,4-dimethylvalero) in the azonitrile series. Nitrile), 2,2′-azobis (2-methylpropionitrile), 2,2′-azobis (2-methylbutyronitrile), 1,1′-azobis (cyclohexane-1-carbonitrile), etc.
  • 2,2′-azobis [N- (2-propenyl) -2-methylpropionamide], 2,2′-azobis [N-butyl-2-methylpropionamide], 2,2′-azobis [ Other azo compounds such as N-cyclohexyl-2-methylpropionamide], 2,2′-azobis (2-methylpropionamide oxime), dimethyl- , 2'-azobis (2-methyl propionate), 4,4'-azobis (4-cyanovaleric acid), 2,2'-azobis (2,4,4-trimethylpentane) and the like.
  • polymerization initiators may be used alone or in combination of two or more.
  • the polymerization initiator can be used in any amount.
  • the total amount of raw material monomers consisting of a monofunctional monomer having an epoxy group, a crosslinkable monomer, and other monomers contained as necessary is 100 parts by mass.
  • it is used in an amount of 0.01 to 15 parts by mass, preferably 0.05 to 10 parts by mass.
  • a method for polymerizing the raw material monomer a known method such as a suspension polymerization method, an emulsion method, a method disclosed in JP-B-58-058026 and JP-A-53-090991 can be used. .
  • a raw material monomer composed of a monofunctional monomer having an epoxy group, the above-described mole percentage of the crosslinkable monomer, and other monomers contained as necessary, a polymerization initiator, and a volume of the above A method of preparing a mixed solution with a diluent and polymerizing by a suspension polymerization method or the like can be used.
  • a polymer ⁇ having a crosslinking degree of 50 mol% to 85 mol% is obtained by performing the above polymerization. Since the degree of crosslinking of the polymer ⁇ is 50 mol% or more, a filler base material having sufficiently high mechanical strength can be obtained. In addition, since the degree of crosslinking of the polymer ⁇ is 85 mol% or less, it is possible to sufficiently ensure the density of the epoxy groups that serve as a foothold for modifying the group derived from the natural polymer on the surface in the step (D). As a result, in the step (D), a filler base material in which a group derived from a natural polymer is sufficiently introduced on the surface is obtained.
  • the polymer ⁇ synthesized by polymerization is a porous organic polymer, and is preferably in the form of particles.
  • the particle size of the particulate polymer ⁇ is not particularly limited, and can be appropriately determined according to the particle size of the target filler base material.
  • the particle size of the particulate polymer ⁇ can be adjusted by the following method.
  • the particle diameter of the polymer ⁇ polymerized by the suspension polymerization method can be adjusted by a method of classifying the polymer ⁇ using a target sieve.
  • the particle size of the polymer ⁇ can be adjusted by a method of controlling the stirring speed and the like during the polymerization.
  • step (B) the epoxy group derived from the monofunctional monomer of the polymer ⁇ is opened to obtain a carrier ⁇ made of a porous organic polymer.
  • ring opening of the epoxy group of the polymer ⁇ means that water is added to the epoxy group of the polymer ⁇ , and the epoxy group is converted to a 1,2-diol group (—CH (OH) —CH 2 —OH). ).
  • the method for ring-opening the epoxy group of the polymer ⁇ is not particularly limited, and any method may be used. Examples thereof include a method using an acidic aqueous solution containing hydrochloric acid, sulfuric acid, phosphoric acid and the like, and a method using a basic aqueous solution containing sodium hydroxide, potassium hydroxide and the like.
  • the presence of 1,2-diol groups in the carrier ⁇ can be confirmed and quantified by a mass change from the polymer ⁇ to the carrier ⁇ . Specifically, the mass of the polymer ⁇ is measured in advance, the epoxy group of the polymer ⁇ is opened to form the carrier ⁇ , the mass of the carrier ⁇ is measured, and the mass of the carrier ⁇ is determined from the mass of the carrier ⁇ . Subtract the mass of This makes it possible to quantify the amount of water added to the epoxy group. In addition, by observing the intensity of the absorption peak before and after the ring opening treatment of the epoxy group from the spectrum of the epoxy group contained in the carrier ⁇ obtained by an infrared spectrophotometer, the progress of the ring opening treatment can be qualitatively determined. It is also possible to grasp.
  • the ratio of the exclusion limit molecular weight and the pore volume in the carrier ⁇ corresponds to the ratio of the exclusion limit molecular weight and the pore volume of the porous organic polymer support (carrier ⁇ ) obtained in the step (C) described later, and the steps described later. This corresponds to the exclusion limit molecular weight and the ratio of the pore volume of the porous organic polymer carrier (carrier ⁇ ) forming the filler base material (carrier ⁇ ) obtained in (D).
  • Step (C) is a step of obtaining a carrier ⁇ (porous organic polymer carrier) by using epichlorohydrin as an epoxidizing agent and using a secondary alcohol as a reaction solvent and introducing an epoxy group into the carrier ⁇ . is there.
  • Epoxidation of the carrier ⁇ means that epichlorohydrin is reacted with the hydroxyl group of the 1,2-diol group generated on the surface of the polymer ⁇ by ring opening of the epoxy group in the step (B), so that the carrier surface It means introducing an epoxy group.
  • the method for obtaining the carrier ⁇ by introducing an epoxy group into the carrier ⁇ is not particularly limited, and any method may be used. Specifically, for example, after mixing the carrier ⁇ , a mixed liquid of epichlorohydrin and a secondary alcohol in a reaction vessel and reacting, mixing of the basic substance and the secondary alcohol in the reaction vessel. The method of adding a liquid and making it react is mentioned. In this embodiment, since a secondary alcohol is used as a reaction solvent in the reaction for introducing an epoxy group into the carrier ⁇ , a carrier ⁇ into which a preferable amount of epoxy is introduced is obtained.
  • secondary alcohols examples include 2-propanol, 2-butanol, 3-methyl-2-butanol, 2-pentanol, and 3-pentanol.
  • the secondary alcohol it is preferable to use 2-propanol which is economically excellent.
  • the base used in the reaction for introducing the epoxy group into the carrier ⁇ to obtain the carrier ⁇ is not particularly limited, and sodium hydride, potassium t-butoxide, sodium methoxide and the like can be suitably used.
  • the density of the epoxy group of the carrier ⁇ is preferably 350 ⁇ mol to 650 ⁇ mol per gram of carrier ⁇ .
  • the density of the epoxy group of the carrier ⁇ is more preferably 440 ⁇ mol / g or more.
  • the density of the epoxy group is 650 ⁇ mol / g or less
  • a plurality of epoxy groups react with one molecule of the natural polymer in immobilization of the group derived from the natural polymer in the step (D) described later. Can be prevented.
  • a high filler substrate is obtained.
  • the density of the epoxy group of the carrier ⁇ is more preferably 570 ⁇ mol / g or less.
  • the method for confirming the density of the epoxy group of the carrier ⁇ is not particularly limited.
  • the following method can be used.
  • the carrier ⁇ obtained by introducing an epoxy group into the carrier ⁇ is reacted with diethylamine to form a carrier ⁇ .
  • the carrier ⁇ is dispersed in an appropriate aqueous solution, and titration with an acid is performed to determine the amount of diethylamino groups of the carrier ⁇ .
  • the number of moles of diethylamino group contained in the carrier ⁇ is determined from the titration value, and this is used as the number of moles of the epoxy group of the carrier ⁇ to calculate the density of the epoxy group.
  • Step (D) is a step in which a natural polymer is immobilized on a carrier ⁇ (porous organic polymer carrier) to obtain a filler base material (carrier ⁇ ).
  • a natural polymer immobilized on the carrier ⁇ it is particularly preferable to use dextran having a weight average molecular weight of 100,000 to 1,000,000.
  • Dextran having a weight average molecular weight of 100,000 to 1,000,000 is preferable because it easily dissolves in water and allows easy introduction of a group derived from a natural polymer into a porous organic polymer carrier.
  • any method may be used as long as it is a method used in a particle surface modification method with a polymer.
  • an epoxy group previously introduced into the carrier ⁇ and / or a reactive functional group (for example, unreacted glycidyl group) present on the surface of the carrier ⁇ itself is reacted with a natural polymer dissolved in water.
  • a reactive functional group for example, unreacted glycidyl group
  • the method of immobilizing a group derived from a natural polymer using an epoxy group introduced into the carrier ⁇ is relatively stable against water, and the reaction with the natural polymer It is preferable from the viewpoint of excellent selectivity.
  • the amount of the group derived from the natural polymer in the carrier ⁇ can be appropriately adjusted depending on the concentration of the natural polymer during the reaction with the carrier ⁇ .
  • the ratio of the mass of the group derived from the natural polymer to the mass of the carrier ⁇ is 200 mg / g to 300 mg / g.
  • the amount of the group derived from the natural polymer immobilized on the carrier ⁇ can be confirmed and quantified by, for example, the mass difference between the carrier ⁇ and the carrier ⁇ . Specifically, the dry mass of the carrier ⁇ before immobilizing the group derived from the natural polymer is calculated by subtracting from the dry mass of the carrier ⁇ .
  • the phenol-sulfuric acid method can be used as a method for calculating the amount of the group derived from the natural polymer of the carrier ⁇ (filler base material). Specifically, phenol and concentrated sulfuric acid are brought into contact with the carrier ⁇ , and the concentration in the supernatant of the furfural derivative generated by decomposition of the polysaccharide-derived component is calculated by measuring the absorbance at a wavelength of 490 nm. This makes it possible to measure the amount of immobilized groups derived from the polysaccharide.
  • filler In the filler of this embodiment, an interactive functional group is covalently bonded to the filler base material described above.
  • the packing material of this embodiment is an organic polymer-based packing material, and is suitably used as a packing material packed in a column when purifying a biopolymer such as protein using chromatography.
  • the interactive functional group that forms the filler is a functional group that interacts with the protein.
  • the interactive functional group include an ion exchange group, a hydrophobic group, and an affinity functional group.
  • the interactive functional group can be appropriately selected according to the use of the filler. For example, when a cation exchange group is selected as the interactive functional group, the filler is a cation exchange resin, and when an anion exchange group is selected, the filler is an anion exchange resin.
  • an ion exchange group As an ion exchange group, well-known things, such as a weak anion exchange group, a strong anion exchange group, a weak cation exchange group, a strong cation exchange group, can be used, for example.
  • the hydrophobic group include, but are not particularly limited to, a butyl group, a heptyl group, an octyl group, and a phenyl group.
  • the affinity functional group include biochemically active substances having affinity for proteins. Examples thereof include Protein A, Protein G, antibody, lectins, and pseudo peptide ligands thereof.
  • the filler is preferably in the form of particles. There is no special restriction
  • the filler is preferably 10 ⁇ m to 300 ⁇ m, more preferably 15 ⁇ m to 200 ⁇ m, and particularly preferably 20 ⁇ m to 100 ⁇ m.
  • the average particle size of the filler of the present invention may be selected according to the purpose, and may be, for example, in the range of 10 to 20 ⁇ m, 20 to 40 ⁇ m, 40 to 80 ⁇ m, 80 to 150 ⁇ m, and the like. If the particle size of the filler is not too small, consolidation is unlikely to occur and use under high flow rate conditions is not difficult. Moreover, if the particle size of the filler is not too large, it is easy to increase the adsorption capacity of the purification object.
  • the average particle diameter is a volume-converted average particle diameter in a wet state.
  • the volume-converted average particle diameter is measured with a Coulter counter or an image analysis type particle size distribution measuring device.
  • an image analysis type particle size distribution measurement device is preferable.
  • a flow type particle image analysis device (trade name: FPIA-3000, manufactured by Sysmex Corporation) can be used.
  • Step (E) is a step of obtaining a carrier ⁇ (filler) in which an interactive functional group is covalently bonded to the carrier ⁇ by introducing an interactive functional group into the carrier ⁇ (substrate for filler). is there.
  • the method of introducing an interactive functional group into the carrier ⁇ and making the carrier ⁇ covalently bound to the interactive functional group is not particularly limited, and the type of the carrier ⁇ and the interactive functional group is not limited. Will be decided accordingly.
  • the amount of the interactive functional group introduced into the carrier ⁇ can be adjusted by the amount of the reagent to be reacted.
  • the introduction of the interactive functional group is preferably performed by a reaction with a hydroxyl group and / or an amino group because it is simple.
  • the reaction between the group derived from the natural polymer of the carrier ⁇ and the interactive functional group is usually used.
  • the hydroxyl group derived from the carrier ⁇ (porous organic polymer carrier) is considered to be probabilistically small, but may be utilized.
  • the interactive functional group is an ion exchange group
  • the method described below can be used. That is, when the base point of the reaction in the group derived from the natural polymer of the carrier ⁇ is a hydroxyl group and / or an amino group, bromoethylsulfonic acid, monochloroacetic acid, chlorohydroxypropanesulfonic acid, 2,3-epoxysulfonic acid, Cation exchange in which a cation exchange group is covalently bonded to a group derived from a natural polymer by reacting 1,3-propane sultone, 1,4-butane sultone, etc.
  • a carrier ⁇ which is a resin
  • a carrier ⁇ which is a resin
  • diethylaminoethyl chloride hydrochloride, glycidyltrimethylammonium hydrochloride, etc. with the hydroxyl group and / or amino group of the carrier ⁇ , an anion exchange group is covalently bonded to the group derived from the natural polymer.
  • a carrier ⁇ which is an anion exchange resin, is obtained.
  • the interactive functional group is a hydrophobic group
  • a hydrophobic carrier ⁇ into which a hydrophobic group has been introduced is obtained.
  • the interactive functional group is an affinity functional group
  • the affinity functional group is immobilized on a group derived from the natural polymer of the carrier ⁇ using a generally used method for immobilizing a ligand of a biochemical substance.
  • a carrier ⁇ is obtained.
  • the protein purification method of the present embodiment includes a step of passing a solution containing the protein through a column packed with the above-described packing material and a step of eluting the protein adsorbed on the packing material.
  • a known method can be used except that the above filler is used.
  • the protein purification method of the present embodiment since the column packed with the above-mentioned packing is used, the amount of biopolymer that can be purified at a time per unit volume is large, and the protein can be efficiently purified under high flow rate processing conditions. .
  • Step (A) Synthesis of Polymer ⁇ -1 A raw material monomer consisting of 14.5 g of glycidyl methacrylate, which is a monofunctional monomer having an epoxy group, and 24.5 g of ethylene glycol dimethacrylate, which is a crosslinkable monomer, 195.5 g of chlorobenzene, which is a diluent, and a polymerization initiator An oil phase was prepared by dissolving 2.4 g of 2,2′-azobis (2,4-dimethylvaleronitrile) and bubbling nitrogen gas for 30 minutes.
  • the mole percentage (crosslinking degree) of the crosslinkable monomer in the raw material monomer was 55 mol%. Moreover, since the diluent was 177.6 ml and the raw material monomer was 35.5 ml, the volume of the diluent was 5.0 times that of the raw material monomer.
  • the aqueous phase and the oil phase were transferred to a separable flask and dispersed with a stirring rod equipped with a half-moon stirring blade at a rotational speed of 430 rpm for 20 minutes. . Thereafter, the aqueous phase was removed by centrifugation, and the resulting polymer was transferred onto a glass filter and washed thoroughly in the order of hot water, denatured alcohol, and water. After washing, sieving classification was performed in a water bath, and water was removed by vacuum filtration for 5 minutes or more to obtain 190 g of a water-wet polymer having a particle size of 25 ⁇ m to 75 ⁇ m. The mass of polymer ⁇ -1 obtained by drying the obtained water-wet polymer was 37 g.
  • Step (B) Ring opening of epoxy group 100 g of water-wet polymer (dry weight 19.5 g of polymer ⁇ -1) was transferred to a separable flask, 500 mL of 0.5 mol / L sulfuric acid aqueous solution was added, and the mixture was heated to 60 ° C. and reacted for 6 hours. Thereafter, the carrier was transferred onto a glass filter and washed with 2000 mL or more of water. Thus, a porous organic polymer carrier (carrier ⁇ -1) in which an epoxy group was opened and a 1,2-diol group was introduced was obtained.
  • the exclusion limit molecular weight and the ratio of the pore volume were determined by the following method.
  • Carrier ⁇ -1 was packed in a chromatography housing having an inner diameter of 4.6 mm and a length of 100 mm to obtain a column.
  • the eluent is water
  • the differential refractive index detector is used as the detector
  • the flow rate is 0.30 mL / min (linear flow rate: 108 cm / hr)
  • the size using pullulan of each molecular weight was performed to generate a calibration curve.
  • the molecular weight of the smallest pullulan among the pullulans having the same elution of the pullulan on the polymer side was defined as the exclusion limit molecular weight.
  • the exclusion limit molecular weight of the carrier ⁇ -1 of Example 1 was 400,000.
  • the amount of eluent obtained from the retention time of pullulan with the molecular weight of the exclusion limit and the multiplier of the flow rate of the eluent was defined as the exclusion limit capacity.
  • the permeation limit capacity was determined from the elution time and flow rate multiplier of ethylene glycol when ethylene glycol was measured.
  • the difference between the exclusion limit capacity and the penetration limit capacity was defined as the pore volume.
  • the ratio of the pore volume was determined by the following formula.
  • Pore volume ratio (%) ⁇ (permeation limit capacity) ⁇ (exclusion limit capacity) ⁇ / ⁇ (volume in column) ⁇ (exclusion limit capacity) ⁇ ⁇ 100 As a result, the ratio of the pore volume of the carrier ⁇ -1 of Example 1 was 98% by volume.
  • the density of introduction of epoxy groups in the obtained carrier ⁇ -1 was measured by the following procedure. As a result of collecting 5.0 g of water-wet carrier (carrier ⁇ -1) and determining the dry mass, it was 0.80 g. Next, the same amount of water-wet carrier ⁇ (carrier ⁇ -1) is weighed into a separable flask, dispersed in 40 g of water, 12 g of diethylamine is added with stirring at room temperature, heated to 50 ° C., and heated to 4 ° C. Stir for hours. After completion of the reaction, the obtained carrier was transferred onto a glass filter, thoroughly washed with water and acetone in that order, and dried under reduced pressure to obtain dry carrier ⁇ -1.
  • the obtained dry carrier ⁇ -1 was transferred to a beaker, dispersed in 150 mL of a 0.5 mol / L aqueous potassium chloride solution, and titrated with 0.1 mol / L hydrochloric acid at the time when the pH reached 4.0. Based on this, the amount of diethylamine introduced into the carrier ⁇ -1 was calculated, and the density of the epoxy group of the carrier ⁇ -1 was calculated according to the following formula. As a result, the density of the epoxy group was 520 ⁇ mol / g.
  • Epoxy group density ( ⁇ mol / g) ⁇ 0.1 ⁇ hydrochloric acid volume at neutralization ( ⁇ l) / dry weight of carrier ⁇ (g) ⁇
  • the amount of dextran immobilized on the obtained carrier ⁇ -1 was calculated by the following procedure. 20 mg of carrier ⁇ -1 (substrate for filler) dried from water-wet carrier ⁇ -1 is weighed into a sample tube, 0.5 mL of water, 0.5 mL of 5% phenol aqueous solution, 2.5 mL of concentrated sulfuric acid, And left to stand for 1 hour. After standing, the absorbance at a wavelength of 490 nm of the 20-fold diluted solution was measured with Infinite M200PRO (trade name, manufactured by Tecan), and the amount of dextran introduced was calculated from the concentration of the furfural derivative contained in the solution. As a result, the amount of dextran immobilized was 250 mg / g based on the mass of the carrier ⁇ -1.
  • Step (E) Introduction of interactive functional group 4.0 g (dry weight 0.72 g) of a water-wet carrier into which dextran was introduced (carrier ⁇ -1) was weighed into a separable flask and dispersed in 4.8 g of water and 5.6 g of 1,3-propane sultone. Heated to 40 ° C. While stirring at 40 ° C., 4.0 g of a 48% aqueous sodium hydroxide solution was added, followed by stirring at 40 ° C. for 3 hours. After completion of the reaction, the carrier was transferred onto a glass filter and washed with water, acetone and water in this order.
  • the carrier was transferred to a beaker, 200 mL of water was added and sufficiently dispersed, and then allowed to stand for 45 minutes. After removing the supernatant, the carrier was washed with water on a glass filter to obtain water- filled filler 1 (carrier ⁇ -1) into which a sulfo group as a cation exchange group was introduced.
  • the obtained filler 1 was packed into a PEEK chromatographic housing (manufactured by Sakai Seisakusho Co., Ltd.) having an inner diameter of 4.0 mm and a length of 50 mm. Filler 1 was filled using a 0.3 mol / L sodium sulfate aqueous solution as a slurry preparation solution at a flow rate of 4.2 mL / min over 20 minutes.
  • the adsorption / elution test was performed by the method shown below, and the adsorption capacity of IgG (iminoglobulin G) was measured. Table 1 shows the measured IgG adsorption capacity. The adsorbed IgG was recovered by fractionating the eluate from the elution step.
  • the adsorption capacity was calculated by the following equation (1).
  • Adsorption capacity (mg / mL-gel) (Amount of liquid delivered at the time of 10% leakage (mL) ⁇ IgG concentration (mg / mL)) / Gel volume (mL-gel) (1)
  • the amount of liquid delivered at the time of 10% leakage is the absorption of the ultraviolet (UV) absorption observed by the detector when the IgG solution was delivered when the column was not installed, and the absorption. This is the total amount of liquid delivered from the beginning of liquid delivery when a 10% UV absorption value was observed.
  • the gel volume is the volume of the packing material, and is the value of the volume when the packing material in the column is transferred to the measuring cylinder and sufficiently settled.
  • Example 2 "Step (E) Introduction of interactive functional group" 4.0 g (dry weight 0.72 g) of a water-wet carrier (carrier ⁇ -1) introduced with dextran obtained in the same manner as in Example 1 was weighed into a separable flask, and 5 mol / L aqueous sodium hydroxide solution was added. The mixture was dispersed in 0 g and stirred at room temperature for 30 minutes. 5.0 g of water in which 3.0 g of diethylaminoethyl chloride hydrochloride was dissolved was added, the temperature was raised to 70 ° C., and the mixture was stirred for 2 hours. After completion of the reaction, the carrier was transferred onto a glass filter and washed with water.
  • the carrier was transferred to a beaker, 200 mL of water was added and sufficiently dispersed, and then allowed to stand for 45 minutes. After removing the supernatant, the carrier was washed with water on a glass filter to obtain a filler 2 (carrier ⁇ -2) into which a diethylamino group as an anion exchange group was introduced.
  • the obtained packing material 2 is filled into a chromatographic housing made of PEEK having an inner diameter of 4.0 mm and a length of 50 mm, and an adsorption / elution test is performed by the following method to measure the adsorption capacity of BSA (bovine serum albumin). did.
  • BSA bovine serum albumin
  • the adsorption capacity of BSA was determined in the same manner as the method for determining the adsorption capacity of IgG in Example 1.
  • Table 1 shows the adsorption capacity of BSA in Example 2.
  • the adsorbed BSA was recovered by separating the eluate from the elution step.
  • BSA adsorption capacity of fillers with anion exchange groups ⁇ Adsorption step> Bovine serum albumin (BSA) concentration: 0.9 mg / mL to 1.1 mg / mL Adsorption buffer: 50 mM Tris hydrochloride buffer (pH 8.5) Feed rate: 1000 cm / hour (flow rate 2.1 mL / Min)
  • BSA bovine serum albumin
  • Example 2 the pressure loss of the column under the high flow rate condition was calculated. The results are shown in Table 1. Moreover, also in Example 2, the phenomenon which a back pressure raises was not seen in the experiment which measures adsorption capacity, and it turned out that the filler 2 has sufficient intensity
  • Step (E) Introduction of interactive functional group 4.0 g (dry weight 0.72 g) of a water-wet carrier (carrier ⁇ -1) introduced with dextran obtained in the same manner as in Example 1 was weighed into a separable flask, 8.0 g of water, and glycidyltrimethylammonium hydrochloride. 4.5g was added and it stirred at 40 degreeC for 8 hours. After completion of the reaction, the carrier was transferred onto a glass filter and washed with water. After washing, the carrier was transferred to a beaker, 200 mL of water was added and sufficiently dispersed, and then allowed to stand for 45 minutes. After removing the supernatant, the carrier was washed with water on a glass filter to obtain a filler 3 (carrier ⁇ -3) into which a trimethylammonium group as an anion exchange group was introduced.
  • Example 3 Using the obtained filler 3, the adsorption capacity of BSA was measured in the same manner as in Example 2. The results are shown in Table 1. Further, in the same manner as in Example 1, the pressure loss of the column under the high flow rate condition was calculated. The results are shown in Table 1. Moreover, also in Example 3, the phenomenon which a back pressure raises was not seen in the experiment which measures adsorption capacity, and it turned out that the filler 3 has sufficient intensity
  • Example 4 In the step of introducing an epoxy group, the amount of epichlorohydrin used was 4.0 g, the amount of potassium t-butoxide was 1.0 g, and the stirring time after heating to 30 ° C. was 6 hours. Except for this, a filler 4 (carrier ⁇ -4) was obtained in the same manner as in Example 1. The introduction density of the epoxy group of the carrier ⁇ -4 obtained in the course of manufacturing the filler 4 and the amount of dextran immobilized on the carrier ⁇ -4 (substrate for filler) were obtained in the same manner as in Example 1. It was. The results are shown in Table 1.
  • Example 4 the IgG adsorption capacity was measured in the same manner as in Example 1. The results are shown in Table 1. Further, in the same manner as in Example 1, the pressure loss of the column under the high flow rate condition was calculated. The results are shown in Table 1. Moreover, also in Example 4, the phenomenon which a back pressure raises was not seen in the experiment which measures adsorption capacity, and it turned out that the filler 4 has sufficient intensity
  • Example 5 In the step of introducing an epoxy group, filler 5 was used in the same manner as in Example 1 except that the amount of epichlorohydrin used was 20.0 g and the amount of potassium tert-butoxide was 5.0 g. (Carrier ⁇ -5) was obtained. The introduction density of the epoxy group of the carrier ⁇ -5 obtained in the course of manufacturing the filler 5 and the amount of dextran immobilized on the carrier ⁇ -5 (substrate for filler) were determined in the same manner as in Example 1. It was. The results are shown in Table 1.
  • Example 5 The adsorption capacity of IgG was measured in the same manner as in Example 1 using the filler 5. The results are shown in Table 1. Further, in the same manner as in Example 1, the pressure loss of the column under the high flow rate condition was calculated. The results are shown in Table 1. Moreover, also in Example 5, the phenomenon which raises back pressure was not seen in the experiment which measures adsorption capacity, and it turned out that the filler 5 has sufficient intensity
  • filler 6 (carrier) was the same as in Example 1 except that the amount of glycidyl methacrylate used was 10.9 g and the amount of ethylene glycol dimethacrylate was 28.2 g. ⁇ -6) was obtained.
  • the carrier ⁇ -6 obtained in the process of producing the filler 6 the exclusion limit molecular weight and the ratio of the pore volume were determined in the same manner as in Example 1. The results are shown in Table 1. Further, the introduction density of the epoxy group of the carrier ⁇ -6 and the amount of dextran immobilized on the carrier ⁇ -6 (substrate for filler) were determined in the same manner as in Example 1. The results are shown in Table 1.
  • Example 6 the IgG adsorption capacity was measured in the same manner as in Example 1. The results are shown in Table 1. Further, in the same manner as in Example 1, the pressure loss of the column under the high flow rate condition was calculated. The results are shown in Table 1. Moreover, also in Example 6, the phenomenon which a back pressure raises was not seen in the experiment which measures adsorption capacity, and it turned out that the filler 6 has sufficient intensity
  • Comparative Example 1 In the step of synthesizing the polymer ⁇ , the filler of Comparative Example 1 was obtained in the same manner as in Example 1 except that the amount of chlorobenzene used as the diluent was 40.6 g. The volume of the diluent in Comparative Example 1 was 1.0 times that of the raw material monomer. For the carrier ⁇ (ratio 1) obtained in the process of producing the filler of Comparative Example 1, the exclusion limit molecular weight and the ratio of the pore volume were determined in the same manner as in Example 1. The results are shown in Table 1.
  • the adsorption capacity of IgG was measured in the same manner as in Example 1 using the filler of Comparative Example 1. The results are shown in Table 1. Further, in the same manner as in Example 1, the pressure loss of the column under the high flow rate condition was calculated. The results are shown in Table 1. Moreover, also in the comparative example 1, the phenomenon which a back pressure raises in the experiment which measures adsorption capacity was not seen, but it turned out that the filler of the comparative example 1 has sufficient intensity
  • Comparative Example 2 A filler of Comparative Example 2 was obtained in the same manner as in Example 1 except that dimethyl sulfoxide was used instead of 2-propanol in the step of introducing an epoxy group.
  • the introduction density of the epoxy group of the carrier ⁇ (ratio 2) obtained in the process of manufacturing the filler of Comparative Example 2 and the amount of dextran immobilized on the carrier ⁇ (ratio 2) (substrate for filler) were carried out. Determined in the same manner as in Example 1. The results are shown in Table 1.
  • the adsorption capacity of IgG was measured in the same manner as in Example 1 using the filler of Comparative Example 2. The results are shown in Table 1. Further, in the same manner as in Example 1, the pressure loss of the column under the high flow rate condition was calculated. The results are shown in Table 1. Moreover, also in the comparative example 2, the phenomenon which a back pressure raises was not seen in the experiment which measures adsorption capacity, and it turned out that the filler of the comparative example 2 has sufficient intensity
  • the adsorption capacity of IgG was measured in the same manner as in Example 1 using the filler of Comparative Example 3. The results are shown in Table 1. Further, in the same manner as in Example 1, the pressure loss of the column under the high flow rate condition was calculated. The results are shown in Table 1. Also in Comparative Example 3, the phenomenon of increasing the back pressure was not observed in the experiment for measuring the adsorption capacity, and it was found that the filler of Comparative Example 3 had sufficient strength.
  • Comparative Example 4 In the step of introducing the natural polymer, the filler of Comparative Example 4 was obtained in the same manner as in Example 1 except that the amount of water used for dissolving dextran 200,000 was 14.4 g. The amount of dextran immobilized on the carrier ⁇ (ratio 4) (base material for filler) obtained in the course of manufacturing the filler of Comparative Example 4 was determined in the same manner as in Example 1. The results are shown in Table 1.
  • the adsorption capacity of IgG was measured in the same manner as in Example 1 using the filler of Comparative Example 4. The results are shown in Table 1. Further, in the same manner as in Example 1, the pressure loss of the column under the high flow rate condition was calculated. The results are shown in Table 1. Moreover, also in the comparative example 4, the phenomenon which raises back pressure was not seen in the experiment which measures adsorption capacity, and it turned out that the filler of the comparative example 4 has sufficient intensity
  • Example 5 In the step of synthesizing the polymer ⁇ , the polymer ⁇ is synthesized in the same manner as in Example 1 except that the amount of glycidyl methacrylate used is 27.8 g and the amount of ethylene glycol dimethacrylate is 11.3 g. did. As a result, the oil phase did not solidify and the polymer ⁇ was not obtained.
  • Comparative Example 6 In the step of synthesizing the polymer ⁇ , the filling of Comparative Example 6 was performed in the same manner as in Example 1 except that the amount of glycidyl methacrylate used was 18.3 g and the amount of ethylene glycol dimethacrylate was 20.8 g. An agent was obtained.
  • the carrier ⁇ (ratio 6) obtained in the process of producing the filler of Comparative Example 6 the exclusion limit molecular weight and the ratio of the pore volume were determined in the same manner as in Example 1. The results are shown in Table 1.
  • the IgG adsorption capacity was measured in the same manner as in Example 1 using the filler of Comparative Example 6. However, the column back pressure increased and the sample could not be fed. In addition, the pressure loss could not be calculated because the column back pressure increased. From this, it can be seen that the filler of Comparative Example 6 has insufficient strength.
  • Table 1 shows the molar percentage (crosslinking degree) of the crosslinkable monomer in the raw material monomers of Examples 1 to 6 and Comparative Examples 1 to 6, the volume ratio of the diluent to the raw material monomer, and the exclusion limit molecular weight of the porous organic polymer carrier.
  • the ratio of the pore volume, the ratio of the mass of the group derived from the natural polymer to the mass of the filler substrate (dextran immobilization amount), the adsorption capacity of the filler and the pressure loss are shown.
  • (IgG) described in the column of adsorption capacity in Table 1 means that it is the adsorption capacity of IgG
  • BSA means that it is the adsorption capacity of BSA.
  • the fillers of Examples 1 to 6 had a higher adsorption capacity than Comparative Examples 1 to 4.
  • Comparative Example 1 since the diluent volume ratio was small, the ratio of the pore volume of the base material for filler was small, and the amount of dextran immobilized was low. As a result, the adsorption capacity of the filler of Comparative Example 1 was low.
  • Comparative Example 2 since dimethyl sulfoxide was used instead of 2-propanol, the amount of dextran immobilized on the base material for filler increased. As a result, the adsorption capacity of the filler of Comparative Example 2 was low. In Comparative Example 3, since ethanol was used instead of 2-propanol, the amount of dextran immobilized on the filler base material was low. As a result, the adsorption capacity of the filler of Comparative Example 3 was low. In Comparative Example 4, since the amount of dextran immobilized on the filler base material was low, the adsorption capacity of the filler was low.
  • Comparative Example 5 a polymer (porous organic polymer) could not be obtained because the degree of crosslinking was insufficient.
  • Comparative Example 6 since the degree of cross-linking of the filler base material was insufficient, the adsorption capacity of the filler was low.
  • the filler of the present invention exhibits a high adsorption capacity for proteins under high flow rate treatment conditions, it is preferably used in the purification of biopolymers.
  • the present invention provides a filler having a sufficient mechanical strength and a high biopolymer adsorption capacity, and a method for producing the filler.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

This base material for a filler comprises a natural polymer immobilized on the surface of a porous organic polymer carrier, the porous organic polymer carrier has a crosslinking degree of 50-85 mol%, the exclusion limit molecular weight is 200,000-800,000, the ratio of pore volume is 96-99 vol%, and the ratio of the mass of groups derived from the natural polymer to the mass of the base material for a filler is 200-300 mg/g.

Description

充填剤用基材、充填剤用基材の製造方法、充填剤およびタンパク質の精製方法Filler base material, filler base material manufacturing method, filler and protein purification method

 本発明は、充填剤用基材、充填剤用基材の製造方法、充填剤およびタンパク質の精製方法に関する。
 本願は、2018年3月29日に、日本に出願された特願2018-063418号に基づき優先権を主張し、その内容をここに援用する。
The present invention relates to a filler substrate, a method for producing a filler substrate, a filler, and a protein purification method.
This application claims priority on March 29, 2018 based on Japanese Patent Application No. 2018-063418 filed in Japan, the contents of which are incorporated herein by reference.

 従来、タンパク質等の生体高分子の吸着、分離、精製には、クロマトグラフィーが用いられている。クロマトグラフィー用の充填剤としては、シリカゲル等の無機系充填剤、アガロース、デキストラン、セルロース、キトサン等の天然高分子系充填剤、およびポリスチレン、ポリ(メタ)アクリレート、ポリ(メタ)アクリルアミド等の有機高分子系充填剤が知られている。これらの充填剤は、そのまま、または多様な分離モードでの使用を可能とするために必要に応じて各種相互作用性官能基を付与して用いられる。 Conventionally, chromatography is used for the adsorption, separation and purification of biopolymers such as proteins. Chromatographic fillers include inorganic fillers such as silica gel, natural polymer fillers such as agarose, dextran, cellulose, chitosan, and organics such as polystyrene, poly (meth) acrylate, poly (meth) acrylamide, etc. Polymeric fillers are known. These fillers are used as they are or with various interactive functional groups added as necessary in order to enable use in various separation modes.

 充填剤を充填したカラムを複数回運用する場合、通常、アルカリ溶液を用いてカラムの洗浄を行う。天然高分子系充填剤および有機高分子系充填剤は、無機系充填剤と比較して、カラムの洗浄に使用されるアルカリ溶液に対する安定性が優れている。
 しかし、天然高分子系充填剤は、機械的強度が不十分である。このため、天然高分子系充填剤を充填したカラムは、高流速処理条件下での使用が困難であった。また、天然高分子系充填剤は、機械的強度が不十分であるため、大スケールカラムでのタンパク質の分離、精製に用いることは困難であった。
When a column filled with a filler is operated multiple times, the column is usually washed with an alkaline solution. Natural polymer fillers and organic polymer fillers are superior in stability to alkaline solutions used for column cleaning compared to inorganic fillers.
However, the natural polymer filler has insufficient mechanical strength. For this reason, a column packed with a natural polymer filler is difficult to use under high flow rate processing conditions. In addition, natural polymer fillers have insufficient mechanical strength, and thus are difficult to use for protein separation and purification on large scale columns.

 したがって、従来、高流速処理条件下で使用されるカラムの充填剤には、ポリスチレン、ポリ(メタ)アクリレート、ポリ(メタ)アクリルアミド等の有機高分子系充填剤が望ましいとされている。 Therefore, conventionally, organic polymer fillers such as polystyrene, poly (meth) acrylate, poly (meth) acrylamide and the like are desirable for the column filler used under high flow rate processing conditions.

 タンパク質等の生体高分子は、分子量が大きい。高流速処理条件下で使用されるカラムにおいて、分子量の大きい分離対象物の吸着容量を高くするには、充填剤として用いられる担体の細孔内部への分離対象物の拡散効率を高める必要がある。細孔内部への分離対象物の拡散効率を高めるためには、担体の細孔径および細孔容積を大きくする必要がある。
 しかし、一般に、細孔径の大きな担体は比表面積が小さいため、分離対象物の吸着容量が十分に得られにくい。また、細孔容積の大きな充填剤は機械的強度が乏しいため、高流速処理条件下での性能が十分に得られないことがあった。
Biopolymers such as proteins have a large molecular weight. In a column used under high flow rate processing conditions, in order to increase the adsorption capacity of the separation target having a large molecular weight, it is necessary to increase the diffusion efficiency of the separation target into the pores of the carrier used as the filler. . In order to increase the diffusion efficiency of the separation object into the pores, it is necessary to increase the pore diameter and pore volume of the support.
However, in general, a carrier having a large pore diameter has a small specific surface area, so that it is difficult to obtain a sufficient adsorption capacity for the separation target. In addition, since the filler having a large pore volume has poor mechanical strength, the performance under a high flow rate treatment condition may not be sufficiently obtained.

 細孔容積の大きな充填剤において、高流速処理条件下での吸着容量を高くする手法の一つとして、有機高分子からなるスペーサーをグラフト重合により基材に導入することが知られている。例えば、特許文献1および非特許文献1では、グラフト重合によって基材に有機高分子を共有結合させた充填剤とすることで、タンパク質の吸着容量の向上に成功している。しかし、グラフト重合による基材への有機高分子の導入は、再現性を得ることが困難であるという欠点があった。 It is known that a spacer made of an organic polymer is introduced into a base material by graft polymerization as one method for increasing the adsorption capacity under a high flow rate processing condition in a filler having a large pore volume. For example, Patent Document 1 and Non-Patent Document 1 succeed in improving the protein adsorption capacity by using a filler in which an organic polymer is covalently bonded to a base material by graft polymerization. However, the introduction of the organic polymer to the base material by graft polymerization has a drawback that it is difficult to obtain reproducibility.

 また、スペーサーとして、デキストラン、プルランといった多糖類を用いる技術も広く知られている。例えば、特許文献2、非特許文献2~4では、アガロース担体に対して平均分子量約40,000のデキストランを固定化し、イオン交換基を導入することで、吸着容量の大幅な向上に成功している。 Also, a technique using a polysaccharide such as dextran or pullulan as a spacer is widely known. For example, in Patent Document 2 and Non-Patent Documents 2 to 4, by successfully immobilizing dextran having an average molecular weight of about 40,000 on an agarose carrier and introducing ion exchange groups, the adsorption capacity was successfully improved. Yes.

 特許文献3には、細孔内部が、多糖類を含有する水溶性直鎖有機高分子により固定化されて満たされ、水溶性直鎖有機高分子部位に、親和性官能基が結合された、多孔質粒子である充填剤が記載されている。特許文献3には、高吸着量のため一度に精製できるタンパク質の量が多く、著しく精製速度を向上させることが可能になる充填剤が記載されている。
また、特許文献3に記載の充填剤は、従来の充填剤よりも硬く、耐久性に優れることが記載されている。
In Patent Document 3, the inside of the pore is filled and fixed with a water-soluble linear organic polymer containing a polysaccharide, and an affinity functional group is bound to the water-soluble linear organic polymer site. Fillers that are porous particles are described. Patent Document 3 describes a filler that has a large amount of protein that can be purified at a time because of its high adsorption amount, and can significantly improve the purification rate.
Moreover, it is described that the filler of patent document 3 is harder than the conventional filler, and is excellent in durability.

 特許文献4には、空孔率が80%以上であり、カラム圧力損失が0.02MPa以上0.2MPa未満である多孔質担体が記載されている。 Patent Document 4 describes a porous carrier having a porosity of 80% or more and a column pressure loss of 0.02 MPa or more and less than 0.2 MPa.

欧州特許第0722360号明細書European Patent No. 0722360 特許第5826180号公報Japanese Patent No. 5826180 特許第5250985号公報Japanese Patent No. 5250985 特開2012-141212号公報JP 2012-141212 A

Journal of Chromatography A,1006(2003)、229-240Journal of Chromatography A, 1006 (2003), 229-240 J.Sep.Sci.2011,34,2950-2959J. et al. Sep. Sci. 2011, 34, 2950-2959 Journal of Chromatography A,1217(2010)5084-5091Journal of Chromatography A, 1217 (2010) 5084-5091 Journal of Chromatography A,1146(2007)202-215Journal of Chromatography A, 1146 (2007) 202-215

 タンパク質等の生体高分子を短時間で多量に精製するために、カラムに充填する充填剤として、十分な機械的強度を有し、高流速処理条件下であっても生体高分子の吸着容量が高いものが要求されている。
 しかしながら、従来の充填剤は、十分な機械的強度を有し、かつ生体高分子の吸着容量が十分に高いものではなかった。このため、充填剤においては、機械的強度を確保しつつ、より一層生体高分子の吸着容量を高くすることが要求されている。
In order to purify a large amount of biopolymers such as proteins in a short time, it has sufficient mechanical strength as a packing material to be packed in the column, and the adsorption capacity of biopolymers is high even under high flow rate processing conditions. A high one is required.
However, the conventional fillers have sufficient mechanical strength and the biopolymer adsorption capacity is not sufficiently high. For this reason, in the filler, it is required to further increase the adsorption capacity of the biopolymer while ensuring the mechanical strength.

 本発明は、上記事情を鑑みてなされたものであり、十分な機械的強度を有し、かつ生体高分子の吸着容量が高い充填剤が得られる充填剤用基材、充填剤用基材の製造方法を提供することを課題とする。
 また、上記の充填剤用基材を用いた十分な機械的強度を有し、かつ生体高分子の吸着容量が高い充填剤、およびこの充填剤を用いるタンパク質の精製方法を提供することを課題とする。
The present invention has been made in view of the above circumstances, and is provided with a filler base material and a filler base material from which a filler having sufficient mechanical strength and a high biopolymer adsorption capacity can be obtained. It is an object to provide a manufacturing method.
Another object of the present invention is to provide a filler having a sufficient mechanical strength using the above-mentioned filler base material and having a high biopolymer adsorption capacity, and a protein purification method using the filler. To do.

 本発明者は、上記課題を解決するために、以下に示すように、鋭意研究を重ねた。
 その結果、以下の(1)~(5)の知見を得た。そして、本発明者は、上記の(1)~(5)の知見に基づいて、本発明を想到した。
(1)架橋度が50mol%~85mol%である多孔質有機高分子担体は、機械的強度が良好であり、前記高分子を用いた充填剤用基材を用いた充填剤は、タンパク質等の生体高分子の吸着容量を高くしても、機械的強度を確保できる。
In order to solve the above-mentioned problems, the present inventor has conducted extensive research as described below.
As a result, the following findings (1) to (5) were obtained. The inventor has conceived the present invention based on the findings (1) to (5) above.
(1) A porous organic polymer carrier having a degree of cross-linking of 50 mol% to 85 mol% has good mechanical strength, and a filler using a base material for filler using the polymer may be a protein or the like. Even if the adsorption capacity of the biopolymer is increased, the mechanical strength can be secured.

(2)排除限界分子量が20万~80万であり、細孔容積の割合が96体積%~99体積%である多孔質有機高分子担体は、各細孔内空間の大きさと細孔数が適切である。このため、これを用いた充填剤用基材を用いた充填剤は、生体高分子の吸着容量が高いものとなる。
(3)充填剤用基材の質量に対する、天然高分子に由来する基の質量の比が、200mg/g~300mg/gとなるように、表面に天然高分子が固定化された充填剤用基材は、天然高分子に由来する基が固定化されていることによるスペーサーとしての効果を十分に発揮でき、細孔容積の割合を確保しつつ、天然高分子に由来する基による生体高分子の吸着容量向上効果が十分に得られる。
(2) A porous organic polymer carrier having an exclusion limit molecular weight of 200,000 to 800,000 and a pore volume ratio of 96 volume% to 99 volume% has a size and number of pores in each pore. Is appropriate. For this reason, the filler using the base material for fillers using this becomes a thing with high adsorption capacity of a biopolymer.
(3) For fillers on which the natural polymer is immobilized on the surface so that the ratio of the mass of the group derived from the natural polymer to the mass of the base material for filler is 200 mg / g to 300 mg / g The base material can sufficiently exhibit the effect as a spacer due to the immobilization of the group derived from the natural polymer, and the biopolymer based on the group derived from the natural polymer while ensuring the ratio of the pore volume. The effect of improving the adsorption capacity is sufficiently obtained.

(4)(1)~(3)の多孔質有機高分子担体の表面に天然高分子が固定化された充填剤用基材に、相互作用性官能基が共有結合している充填剤は、相互作用性官能基の種類を選択することにより、用途に応じた充填剤とすることができる。
(5)(4)の充填剤は、高流速処理条件下であっても生体高分子の吸着容量が高いものであるため、タンパク質等の生体高分子を短時間で多量に精製できる。
(4) A filler in which an interactive functional group is covalently bonded to a filler base material in which a natural polymer is immobilized on the surface of a porous organic polymer carrier of (1) to (3), By selecting the type of the interactive functional group, a filler according to the application can be obtained.
(5) Since the filler of (4) has a high biopolymer adsorption capacity even under high flow rate processing conditions, a large amount of biopolymer such as protein can be purified in a short time.

 また、本発明者は、以下の方法により、すなわち、エポキシ基を有する単官能性モノマーと所定量の架橋性モノマーとを含む原料モノマーを、所定量の希釈剤および重合開始剤の存在下で重合して重合物とした後、重合物の単官能性モノマーに由来するエポキシ基を開環してエピクロロヒドリンと2級アルコールを用いてエポキシ基を導入し、200mg/g~300mg/gの天然高分子に由来する基を固定化することにより、上記の充填剤用基材が得られることを見出し、本発明を完成するに至った。
 すなわち、本発明の第一の態様は、以下の[1]に記載される基材を提供する。
Further, the present inventor polymerizes a raw material monomer containing a monofunctional monomer having an epoxy group and a predetermined amount of a crosslinkable monomer in the presence of a predetermined amount of a diluent and a polymerization initiator by the following method. Then, the epoxy group derived from the monofunctional monomer of the polymer is ring-opened and the epoxy group is introduced using epichlorohydrin and secondary alcohol, and 200 mg / g to 300 mg / g It discovered that said base material for fillers was obtained by fix | immobilizing the group derived from a natural polymer, and came to complete this invention.
That is, the first aspect of the present invention provides a substrate described in the following [1].

[1]多孔質有機高分子担体の表面に天然高分子が固定化された充填剤用基材であり、
 前記多孔質有機高分子担体は、架橋度が50mol%~85mol%であり、排除限界分子量が20万~80万であり、細孔容積の割合が96体積%~99体積%であり、
 前記充填剤用基材の質量に対する天然高分子に由来する基の質量の比が、200mg/g~300mg/gである充填剤用基材。
[1] A filler base material in which a natural polymer is immobilized on the surface of a porous organic polymer carrier,
The porous organic polymer carrier has a cross-linking degree of 50 mol% to 85 mol%, an exclusion limit molecular weight of 200,000 to 800,000, and a pore volume ratio of 96 vol% to 99 vol%.
A filler base material having a ratio of a mass of a group derived from a natural polymer to a mass of the filler base material of 200 mg / g to 300 mg / g.

本発明の第一の態様の基材は、以下の特徴を好ましく含むことができる。
[2]前記天然高分子が、多糖類である、[1]に記載の充填剤用基材。
[3]前記多糖類が、デキストランである、[2]に記載の充填剤用基材。
The base material of the first aspect of the present invention can preferably include the following features.
[2] The filler base material according to [1], wherein the natural polymer is a polysaccharide.
[3] The filler base material according to [2], wherein the polysaccharide is dextran.

 本発明の第二の態様は、以下の[4]に記載される充填剤を提供する。
[4][1]~[3]のいずれかに記載の充填剤用基材に、相互作用性官能基が共有結合している、充填剤。
 本発明の第二の態様は、以下の特徴を好ましく含むことができる。
[5]前記相互作用性官能基が、陽イオン交換基である、[4]に記載の充填剤。
[6]前記相互作用性官能基が、陰イオン交換基である、[4]に記載の充填剤。
The second aspect of the present invention provides the filler described in [4] below.
[4] A filler in which an interactive functional group is covalently bonded to the filler substrate according to any one of [1] to [3].
The second aspect of the present invention can preferably include the following features.
[5] The filler according to [4], wherein the interactive functional group is a cation exchange group.
[6] The filler according to [4], wherein the interactive functional group is an anion exchange group.

 本発明の第三の態様は、以下の[7]に記載される充填剤用基材の製造方法である。
[7][1]~[3]のいずれかに記載の充填剤用基材の製造方法であり、
 エポキシ基を有する単官能性モノマーと架橋性モノマーとを含む原料モノマーを、希釈剤および重合開始剤の存在下で重合して重合物αを得る工程であって、
 前記原料モノマー中の前記架橋性モノマー濃度を50mol%~85mol%とし、前記希釈剤を前記原料モノマーの3.8倍~5.8倍の容積で使用する工程(A)と、
 前記重合物αの単官能性モノマーに由来するエポキシ基を開環して多孔質有機高分子からなる担体βを得る工程(B)と、
 エピクロロヒドリンと2級アルコールとを用いて前記担体βにエポキシ基を導入し、担体γを得る工程(C)と、
 前記担体γに天然高分子を固定化して担体δを得る工程であって、前記担体δの質量に対する天然高分子に由来する基の質量の比を200mg/g~300mg/gとする工程(D)とを有する、充填剤用基材の製造方法。
The third aspect of the present invention is a method for producing a filler substrate described in [7] below.
[7] A method for producing a filler substrate according to any one of [1] to [3],
A step of polymerizing a raw material monomer containing a monofunctional monomer having an epoxy group and a crosslinkable monomer in the presence of a diluent and a polymerization initiator to obtain a polymer α,
A step (A) in which the concentration of the crosslinkable monomer in the raw material monomer is 50 mol% to 85 mol%, and the diluent is used in a volume of 3.8 times to 5.8 times the raw material monomer;
A step (B) of obtaining a carrier β comprising a porous organic polymer by opening an epoxy group derived from a monofunctional monomer of the polymer α;
A step (C) of obtaining a carrier γ by introducing an epoxy group into the carrier β using epichlorohydrin and a secondary alcohol;
A step of obtaining a carrier δ by immobilizing a natural polymer on the carrier γ, wherein the ratio of the mass of the group derived from the natural polymer to the mass of the carrier δ is 200 mg / g to 300 mg / g (D The manufacturing method of the base material for fillers which has these.

 本発明の第三の態様は、以下の特徴を好ましく含むことができる。
[8]前記エポキシ基を有する単官能性モノマーがグリシジルメタクリレートであり、
 前記架橋性モノマーがエチレングリコールジメタクリレートであり、
 前記希釈剤がクロロベンゼンであり、
 前記2級アルコールが2-プロパノールである、[7]に記載の充填剤用基材の製造方法。
[9]前記天然高分子が、重量平均分子量10万~100万のデキストランである、[7]または[8]に記載の充填剤用基材の製造方法。
[10]前記担体γのエポキシ基の密度が、担体γ1g当たり350μmol~650μmolである、[7]~[9]のいずれかに記載の充填剤用基材の製造方法。
The third aspect of the present invention can preferably include the following features.
[8] The monofunctional monomer having an epoxy group is glycidyl methacrylate,
The crosslinkable monomer is ethylene glycol dimethacrylate;
The diluent is chlorobenzene,
[7] The method for producing a filler base material according to [7], wherein the secondary alcohol is 2-propanol.
[9] The method for producing a filler base material according to [7] or [8], wherein the natural polymer is dextran having a weight average molecular weight of 100,000 to 1,000,000.
[10] The method for producing a filler base material according to any one of [7] to [9], wherein the density of the epoxy group of the carrier γ is 350 μmol to 650 μmol per gram of carrier γ.

 本発明の第四の態様は、以下の[11]に記載されるタンパク質の精製方法である。
[11]タンパク質を含む溶液を、[4]~[6]のいずれかに記載の充填剤が充填されたカラムに通液する工程と、
 前記充填剤に吸着されたタンパク質を溶出させる工程とを含むタンパク質の精製方法。
The fourth aspect of the present invention is a protein purification method described in [11] below.
[11] A step of passing a solution containing protein through a column packed with the packing material according to any one of [4] to [6];
And a step of eluting the protein adsorbed on the filler.

 本発明の充填剤用基材に、相互作用性官能基が共有結合している充填剤は、十分な機械的強度を有し、かつタンパク質等の生体高分子の吸着容量が高い。本発明の充填剤は、単位体積当たりの一度に精製できる生体高分子の量が多く、精製速度の向上に寄与でき、高流速処理条件下で好適に用いることができる。 The filler in which the interactive functional group is covalently bonded to the filler base material of the present invention has sufficient mechanical strength and a high adsorption capacity for biopolymers such as proteins. The filler of the present invention has a large amount of biopolymer that can be purified at one time per unit volume, can contribute to an improvement in purification rate, and can be suitably used under high flow rate treatment conditions.

 以下、本発明の充填剤用基材、充填剤用基材の製造方法、充填剤およびタンパク質の精製方法の好ましい例を詳細に説明する。なお、以下に示す実施形態は、発明の趣旨をより良く理解させるために具体的に説明するものであり、特に指定のない限り、本発明を限定するものではない。本発明の趣旨を逸脱しない範囲で、構成の付加、省略、置換、組み合わせおよびその他の変更が可能である。
 なお、本明細書において、「(メタ)アクリル」とは、「アクリル」と「メタクリル」の一方または両方を意味する。
Hereinafter, preferred examples of the filler substrate, the filler substrate production method, the filler, and the protein purification method of the present invention will be described in detail. The following embodiments are specifically described for better understanding of the gist of the invention, and do not limit the present invention unless otherwise specified. Additions, omissions, substitutions, combinations, and other modifications can be made without departing from the spirit of the present invention.
In the present specification, “(meth) acryl” means one or both of “acryl” and “methacryl”.

[充填剤用基材]
 本実施形態の充填剤用基材は、多孔質有機高分子担体の表面に天然高分子が固定化されたものである。
 多孔質有機高分子担体は、架橋度が50mol%~85mol%であり、排除限界分子量が20万~80万であり、細孔容積の割合が96体積%~99体積%である。
[Base material for filler]
The base material for filler of the present embodiment is one in which a natural polymer is immobilized on the surface of a porous organic polymer carrier.
The porous organic polymer carrier has a crosslinking degree of 50 mol% to 85 mol%, an exclusion limit molecular weight of 200,000 to 800,000, and a pore volume ratio of 96 vol% to 99 vol%.

 多孔質有機高分子担体の架橋度が、50mol%~85mol%であると、これを用いた充填剤用基材は、タンパク質等の生体高分子の吸着容量が高く、かつ、十分な機械的強度を有するものとなる。多孔質有機高分子担体の架橋度は、55mol%~70mol%であることが好ましい。多孔質有機高分子担体の架橋度が50mol%未満であると、機械的強度が不足して、これを用いた充填剤用基材を含む充填剤は、高流速処理条件下で使用できない。多孔質有機高分子担体の架橋度が85mol%超であると、天然高分子に由来する基が表面に十分に導入されないため、これを用いた充填剤用基材の生体高分子の吸着容量が不足する。 When the degree of cross-linking of the porous organic polymer carrier is 50 mol% to 85 mol%, the filler base material using the porous organic polymer carrier has a high adsorption capacity for biopolymers such as proteins and sufficient mechanical strength. It will have. The degree of crosslinking of the porous organic polymer carrier is preferably 55 mol% to 70 mol%. When the degree of cross-linking of the porous organic polymer carrier is less than 50 mol%, the mechanical strength is insufficient, and a filler including a filler base material using the porous organic polymer carrier cannot be used under high flow rate processing conditions. If the degree of cross-linking of the porous organic polymer carrier is more than 85 mol%, the group derived from the natural polymer is not sufficiently introduced to the surface. Run short.

 多孔質有機高分子担体の排除限界分子量は20万~80万であり、30万~50万であることがより好ましい。多孔質有機高分子担体の排除限界分子量が20万以上であると、これを用いた充填剤用基材はタンパク質等の生体高分子の吸着容量が高いものとなる。排除限界分子量が80万以下であると、これを用いた充填剤用基材は、十分な機械的強度を有するものとなる。 The exclusion limit molecular weight of the porous organic polymer carrier is 200,000 to 800,000, more preferably 300,000 to 500,000. When the exclusion limit molecular weight of the porous organic polymer carrier is 200,000 or more, the base material for filler using the porous organic polymer carrier has a high adsorption capacity for biopolymers such as proteins. When the exclusion limit molecular weight is 800,000 or less, the filler base material using the molecular weight has sufficient mechanical strength.

 多孔質有機高分子担体の細孔容積の割合(充填剤の全容積に対する細孔の容積の割合)は96体積%~99体積%である。細孔容積の割合が96体積%以上であると、これを用いた充填剤用基材はタンパク質等の生体高分子の吸着容量が高いものとなる。また、細孔容積の割合が99体積%以下であると、これを用いた充填剤用基材は、十分な機械的強度を有する充填剤が得られる。 The ratio of the pore volume of the porous organic polymer carrier (ratio of the volume of the pores to the total volume of the filler) is 96% to 99% by volume. When the proportion of the pore volume is 96% by volume or more, the base material for filler using this has a high adsorption capacity for biopolymers such as proteins. In addition, when the proportion of the pore volume is 99% by volume or less, a filler having sufficient mechanical strength can be obtained from the filler base material using the pore volume.

 多孔質有機高分子担体の表面に固定化された天然高分子としては、水に溶解するものであれば特に限定はなく、骨格に水酸基、アミノ基を有する直鎖状有機高分子が好ましい。
直鎖状有機高分子としては、例えば、分子内に複数の水酸基を有する親水性の高い多糖類を用いることが好ましい。多糖類としては、具体的には、アガロース、デキストラン、プルラン、デンプン、セルロースおよびその誘導体等が挙げられる。これらの多糖類の中でも特に、水溶性が高く、多孔質有機高分子担体への導入が比較的容易であるため、デキストランを用いることが好ましい。
The natural polymer immobilized on the surface of the porous organic polymer carrier is not particularly limited as long as it is soluble in water, and a linear organic polymer having a hydroxyl group and an amino group in the skeleton is preferable.
As the linear organic polymer, for example, a highly hydrophilic polysaccharide having a plurality of hydroxyl groups in the molecule is preferably used. Specific examples of the polysaccharide include agarose, dextran, pullulan, starch, cellulose, and derivatives thereof. Among these polysaccharides, dextran is preferably used because of its high water solubility and relatively easy introduction into a porous organic polymer carrier.

 天然高分子の重量平均分子量としては、特に限定されないが、好ましくは5,000~5,000,000、更に好ましくは100,000~1,000,000である。天然高分子の重量平均分子量が5,000以上であると、固定化された天然高分子に由来する基による吸着量向上効果がより顕著となる。また、天然高分子の分子量が、5,000,000以下であると、固定化された天然高分子に由来する基が充填剤用基材の細孔内空間の大多数を占めることにより、タンパク質等の高分子量の分離対象物が細孔内空間に拡散浸透する余地がなくなることを防止できる。 The weight average molecular weight of the natural polymer is not particularly limited, but is preferably 5,000 to 5,000,000, and more preferably 100,000 to 1,000,000. When the weight average molecular weight of the natural polymer is 5,000 or more, the effect of improving the adsorption amount by the group derived from the immobilized natural polymer becomes more remarkable. Further, when the molecular weight of the natural polymer is 5,000,000 or less, the group derived from the immobilized natural polymer occupies the majority of the pore internal space of the base material for filler, thereby Thus, it is possible to prevent the room for separation and penetration of the high molecular weight separation object such as the like into the space in the pore.

 充填剤用基材の質量に対する天然高分子に由来する基の質量の比は、200mg/g~300mg/gであり、好ましくは210mg/g~280mg/gである。天然高分子に由来する基の質量の比が200mg/g以上であると、充填剤用基材において天然高分子に由来する基による生体高分子の吸着容量向上効果が十分に得られる。天然高分子に由来する基の質量の比が300mg/g以下であると、充填剤用基材に固定化された天然高分子に由来する基が多孔質有機高分子担体の細孔内空間の大多数を占めることにより、タンパク質等の高分子量の分離対象物が細孔内空間に拡散浸透する余地が少なくなることを防止できる。 The ratio of the mass of the group derived from the natural polymer to the mass of the base material for filler is 200 mg / g to 300 mg / g, preferably 210 mg / g to 280 mg / g. When the mass ratio of the group derived from the natural polymer is 200 mg / g or more, the effect of improving the adsorption capacity of the biopolymer by the group derived from the natural polymer is sufficiently obtained in the filler base material. When the mass ratio of the group derived from the natural polymer is 300 mg / g or less, the group derived from the natural polymer immobilized on the filler base material is in the pore space of the porous organic polymer carrier. By occupying the majority, it is possible to prevent a room for high-molecular-weight separation objects such as proteins from diffusing and penetrating into the pore space.

[充填剤用基材の製造方法]
 次に、本実施形態の充填剤用基材の製造方法について説明する。
 本実施形態の充填剤用基材の製造方法は、以下に示す工程(A)~工程(D)を有する。
 工程(A)は、エポキシ基を有する単官能性モノマーと架橋性モノマーとを含む原料モノマーを、希釈剤および重合開始剤の存在下で重合して重合物αを得る工程である。工程(A)では、原料モノマー中の架橋性モノマー濃度を50mol%~85mol%とし、希釈剤を原料モノマーの3.8倍~5.8倍の容積で使用する。
[Manufacturing method of base material for filler]
Next, the manufacturing method of the base material for fillers of this embodiment is demonstrated.
The method for producing a filler base material of the present embodiment includes the following steps (A) to (D).
Step (A) is a step of obtaining a polymer α by polymerizing a raw material monomer containing a monofunctional monomer having an epoxy group and a crosslinkable monomer in the presence of a diluent and a polymerization initiator. In the step (A), the concentration of the crosslinkable monomer in the raw material monomer is set to 50 mol% to 85 mol%, and the diluent is used in a volume of 3.8 times to 5.8 times that of the raw material monomer.

 工程(B)は、重合物αの単官能性モノマーに由来するエポキシ基を開環して多孔質有機高分子からなる担体βを得る工程である。
 工程(C)は、エピクロロヒドリンと2級アルコールとを用いて担体βにエポキシ基を導入し、担体γを得る工程である。
 工程(D)は、担体γに天然高分子を固定化して、本実施形態の充填剤用基材(以下、「担体δ」という場合がある。)を得る工程である。工程(D)では、担体δの質量に対する天然高分子に由来する基の質量の比を200mg/g~300mg/gとする。
Step (B) is a step of obtaining a carrier β made of a porous organic polymer by opening an epoxy group derived from a monofunctional monomer of the polymer α.
Step (C) is a step of obtaining a carrier γ by introducing an epoxy group into the carrier β using epichlorohydrin and a secondary alcohol.
Step (D) is a step of obtaining the base material for filler of the present embodiment (hereinafter sometimes referred to as “carrier δ”) by immobilizing the natural polymer on the carrier γ. In the step (D), the ratio of the mass of the group derived from the natural polymer to the mass of the carrier δ is set to 200 mg / g to 300 mg / g.

「工程(A)」
 工程(A)では、エポキシ基を有する単官能性モノマーと架橋性モノマーとを含む原料モノマーを、希釈剤および重合開始剤の存在下で重合して重合物αを得る。
 重合物αを合成する際に用いられるエポキシ基を有する単官能性モノマーは、エチレン性炭素-炭素2重結合(重合性官能基という)を1つのみを有する化合物である。架橋性モノマーは、重合性官能基を複数有する化合物である。原料モノマーは、必要に応じて、エポキシ基を有する単官能性モノマーおよび架橋性モノマーではない他のモノマーを含んでいてもよい。
"Process (A)"
In the step (A), a raw material monomer containing a monofunctional monomer having an epoxy group and a crosslinkable monomer is polymerized in the presence of a diluent and a polymerization initiator to obtain a polymer α.
The monofunctional monomer having an epoxy group used when synthesizing the polymer α is a compound having only one ethylenic carbon-carbon double bond (referred to as a polymerizable functional group). The crosslinkable monomer is a compound having a plurality of polymerizable functional groups. The raw material monomer may contain a monofunctional monomer having an epoxy group and another monomer that is not a crosslinkable monomer, if necessary.

(エポキシ基を有する単官能性モノマー)
 エポキシ基を有する単官能性モノマーとしては、特に限定されるものではなく、例えば、グリシジル(メタ)アクリレート、4,5-エポキシペンチル(メタ)アクリレート、4-(2,3-エポキシプロピル)-n-ブチル(メタ)アクリレート、9,10-エポキシステアリルアクリレート、4-(2,3-エポキシプロピル)シクロヘキシルメチルアクリレート、アリルグリシジルエーテルなどのエポキシ化合物類、3,4-エポキシシクロヘキシルメチル(メタ)アクリレート、3,4-エポキシシクロヘキシルエチル(メタ)アクリレート、3,4-エポキシシクロヘキシルプロピル(メタ)アクリレート、ビニルベンジルグリシジルエーテルなどの脂環式エポキシ化合物類が例示される。これらのエポキシ基を有する単官能性モノマーは、単独で用いても良いし、2種類以上を混合して用いても良い。
(Monofunctional monomer having an epoxy group)
The monofunctional monomer having an epoxy group is not particularly limited. For example, glycidyl (meth) acrylate, 4,5-epoxypentyl (meth) acrylate, 4- (2,3-epoxypropyl) -n -Epoxy compounds such as butyl (meth) acrylate, 9,10-epoxystearyl acrylate, 4- (2,3-epoxypropyl) cyclohexylmethyl acrylate, allyl glycidyl ether, 3,4-epoxycyclohexylmethyl (meth) acrylate, Examples include alicyclic epoxy compounds such as 3,4-epoxycyclohexylethyl (meth) acrylate, 3,4-epoxycyclohexylpropyl (meth) acrylate, and vinylbenzyl glycidyl ether. These monofunctional monomers having an epoxy group may be used alone or in combination of two or more.

 エポキシ基を有する単官能性モノマーとしては、上述した化合物の中でも、グリシジル(メタ)アクリレート、3,4-エポキシシクロヘキシルメチル(メタ)アクリレートのいずれか一方または両方を含むことが好ましく、特に、グリシジル(メタ)アクリレートを含むことが好ましく、市販で容易に入手可能であるため、グリシジルメタクリレートを用いることが最も好ましい。 The monofunctional monomer having an epoxy group preferably includes one or both of glycidyl (meth) acrylate and 3,4-epoxycyclohexylmethyl (meth) acrylate among the above-mentioned compounds. It is preferable to use glycidyl methacrylate because it preferably contains (meth) acrylate and is readily available commercially.

(架橋性モノマー)
 架橋性モノマーとしては、特に限定されるものではなく、複数の重合性官能基を有するモノマーを用いることができる。2官能性モノマーとしては、例えば、ジビニルベンゼンなどのジビニル芳香族化合物、エチレングリコールジ(メタ)アクリレート、ポリエチレングリコールジ(メタ)アクリレートなどのアルキレングリーコール-ジ(メタ)アクリレート類、アルキレン(炭素数1~11)ビス(メタ)アクリレート類、N,N’-メチレンビス(メタ)アクリルアミド、N,N’-エチレン-ビス(メタ)アクリルアミド、N,N’-ヘキサメチレン-ビス(メタ)アクリルアミドなどのアルキレン(炭素数1~11)ビス(メタ)アクリルアミド類などが例示できる。3官能性モノマーとしては、例えば、トリビニルベンゼン、グリセリントリ(メタ)アクリレートなどが挙げられる。これらの架橋性モノマーは、単独で用いても良いし、2種類以上を混合して用いても良い。
 架橋性モノマーとしては、上述した化合物の中でも、エチレングリコールジメタクリレートを含むことが好ましく、タンパク質を吸着するのに十分な容積を有する細孔を容易に形成できるエチレングリコールジメタクリレートを単独で用いることが最も好ましい。
(Crosslinkable monomer)
The crosslinkable monomer is not particularly limited, and a monomer having a plurality of polymerizable functional groups can be used. Examples of the bifunctional monomer include divinyl aromatic compounds such as divinylbenzene, alkylene glycol-di (meth) acrylates such as ethylene glycol di (meth) acrylate and polyethylene glycol di (meth) acrylate, alkylene (carbon number) 1-11) Bis (meth) acrylates, N, N′-methylenebis (meth) acrylamide, N, N′-ethylene-bis (meth) acrylamide, N, N′-hexamethylene-bis (meth) acrylamide, etc. Examples include alkylene (having 1 to 11 carbon atoms) bis (meth) acrylamides. Examples of the trifunctional monomer include trivinylbenzene and glycerin tri (meth) acrylate. These crosslinkable monomers may be used alone or in combination of two or more.
Among the above-mentioned compounds, the crosslinkable monomer preferably contains ethylene glycol dimethacrylate, and it is preferable to use ethylene glycol dimethacrylate alone, which can easily form pores having a volume sufficient to adsorb proteins. Most preferred.

 原料モノマー中の架橋性モノマー濃度は、重合物αの架橋度に対応し、後述する工程(D)で得られる充填剤用基材(担体δ)の架橋度に対応する。
 すなわち、重合物αの架橋度は、重合物αの重合に使用した原料モノマー中の架橋性モノマーのモル百分率(mol%)を示す値であり、以下に示す式で求められる。
 重合物αの架橋度(mol%)=(架橋性モノマーのモル数/原料モノマーのモル数)×100
The crosslinkable monomer concentration in the raw material monomer corresponds to the degree of crosslinking of the polymer α, and corresponds to the degree of crosslinking of the base material for filler (carrier δ) obtained in the step (D) described later.
That is, the degree of cross-linking of the polymer α is a value indicating the mole percentage (mol%) of the cross-linkable monomer in the raw material monomer used for the polymerization of the polymer α, and is obtained by the following formula.
Degree of crosslinking of polymer α (mol%) = (number of moles of crosslinking monomer / number of moles of raw material monomer) × 100

 本実施形態では、原料モノマー中の架橋性モノマーのモル百分率を50mol%~85mol%とする。このことにより、架橋度が50mol%~85mol%である重合物αが得られ、工程(D)において、架橋度が50mol%~85mol%である充填剤用基材(担体δ)が得られる。原料モノマー中の架橋性モノマーのモル百分率は、架橋度が55mol%~70mol%である充填剤用基材(担体δ)が得られるように、55mol%~70mol%とすることが好ましい。 In this embodiment, the mole percentage of the crosslinkable monomer in the raw material monomer is 50 mol% to 85 mol%. As a result, a polymer α having a crosslinking degree of 50 mol% to 85 mol% is obtained, and in the step (D), a filler base material (carrier δ) having a crosslinking degree of 50 mol% to 85 mol% is obtained. The molar percentage of the crosslinkable monomer in the raw material monomer is preferably 55 mol% to 70 mol% so that a filler base material (carrier δ) having a crosslinking degree of 55 mol% to 70 mol% can be obtained.

(他のモノマー)
 エポキシ基を有する単官能性モノマーおよび架橋性モノマーではない他のモノマーとしては、不飽和官能基を有するモノマーを用いることができ、特に限定されるものではない。他のモノマーとしては、例えば、スチレン、メチルスチレン、エチルスチレン、ヒドロキシスチレン、クロロスチレンなどの芳香族モノマー類、メチル(メタ)アクリレート、エチル(メタ)アクリレート、ヒドロキシエチル(メタ)アクリレート、ヒドロキシプロピル(メタ)アクリレート、ヒドロキシブチル(メタ)アクリレート、ヒドロキシペンチル(メタ)アクリレート、2-クロロエチル(メタ)アクリレート、ポリエチレングリコール(メタ)アクリレートなどの(メタ)アクリレート類、ジメチル(メタ)アクリルアミド、ジエチル(メタ)アクリルアミド、ヒドロキシエチル(メタ)アクリルアミド、ヒドロキシプロピル(メタ)アクリルアミド、ヒドロキシブチル(メタ)アクリルアミドなどの(メタ)アクリルアミド類、ハロアルキル(炭素数1~4)ビニルエーテル、ヒドロキシアルキル(炭素数1~4)ビニルエーテル、ビニルアセテート等を例示できる。
(Other monomers)
As the monofunctional monomer having an epoxy group and the other monomer that is not a crosslinkable monomer, a monomer having an unsaturated functional group can be used and is not particularly limited. Examples of other monomers include aromatic monomers such as styrene, methylstyrene, ethylstyrene, hydroxystyrene, and chlorostyrene, methyl (meth) acrylate, ethyl (meth) acrylate, hydroxyethyl (meth) acrylate, hydroxypropyl ( (Meth) acrylate, hydroxybutyl (meth) acrylate, hydroxypentyl (meth) acrylate, 2-chloroethyl (meth) acrylate, (meth) acrylates such as polyethylene glycol (meth) acrylate, dimethyl (meth) acrylamide, diethyl (meth) (Meth) acrylamides such as acrylamide, hydroxyethyl (meth) acrylamide, hydroxypropyl (meth) acrylamide, and hydroxybutyl (meth) acrylamide Haloalkyl (1-4 carbon atoms) vinyl ether, hydroxyalkyl (1-4 carbon atoms) vinyl ether, vinyl acetate and the like.

(希釈剤)
 本実施形態において、エポキシ基を有する単官能性モノマーと、架橋性モノマーと、必要に応じて含有される他のモノマーとからなる原料モノマーを重合する際には、希釈剤が用いられる。希釈剤を用いることにより、多孔質の重合物αが得られる。
 希釈剤としては、原料モノマーを溶解でき、重合反応条件下で原料モノマーおよび重合開始剤と均一に混合可能であり、原料モノマーを重合して得た重合物αを溶解せず、重合反応に不活性な有機溶媒を用いることができる。このような有機溶媒は、原料モノマーの種類により異なり、任意に選択できる。
(Diluent)
In this embodiment, a diluent is used when polymerizing a raw material monomer composed of a monofunctional monomer having an epoxy group, a crosslinkable monomer, and other monomers contained as necessary. By using a diluent, a porous polymer α can be obtained.
As the diluent, the raw material monomer can be dissolved, and can be uniformly mixed with the raw material monomer and the polymerization initiator under the polymerization reaction conditions. The polymer α obtained by polymerizing the raw material monomer is not dissolved, and the polymerization reaction is not performed. An active organic solvent can be used. Such an organic solvent varies depending on the type of raw material monomer and can be arbitrarily selected.

 希釈剤としては、例えば、クロロベンゼン、トルエン、キシレン、ジエチルベンゼン、ドデシルベンゼン等の芳香族炭化水素類、ヘキサン、ヘプタン、デカン等の飽和炭化水素類、イソアミルアルコール、ヘキシルアルコール、オクチルアルコール等のアルコール類などを用いることができる。これらの希釈剤は、単独で用いても良いし、2種類以上を混合して用いても良い。
 上述した希釈剤の中でも特に、生体高分子を吸着するのに十分な細孔径が得られるため、クロロベンゼンを用いることが好ましい。
Examples of the diluent include aromatic hydrocarbons such as chlorobenzene, toluene, xylene, diethylbenzene and dodecylbenzene, saturated hydrocarbons such as hexane, heptane and decane, alcohols such as isoamyl alcohol, hexyl alcohol and octyl alcohol. Can be used. These diluents may be used alone or in combination of two or more.
Among the diluents described above, chlorobenzene is preferably used because a pore size sufficient to adsorb the biopolymer can be obtained.

 希釈剤は、原料モノマーの容積の3.8倍~5.8倍の容積で使用する。希釈剤の容積と原料モノマーの容積との割合を算出する際には、混合物である原料モノマーの体積(容積)と希釈剤の体積(容積)を、各々室温で測定した時の値を使用する。希釈剤の使用量を調整することにより、重合物αおよび充填剤用基材(担体δ)における排除限界分子量および細孔容積の割合を変化させることができる。 Diluent is used in a volume of 3.8 to 5.8 times the volume of the raw material monomer. When calculating the ratio between the volume of the diluent and the volume of the raw material monomer, the values obtained by measuring the volume (volume) of the raw material monomer as a mixture and the volume (volume) of the diluent, respectively, at room temperature are used. . By adjusting the use amount of the diluent, the exclusion limit molecular weight and the ratio of the pore volume in the polymer α and the filler base material (carrier δ) can be changed.

 使用する希釈剤の容積を、原料モノマーの容積の3.8倍以上とすることで、排除限界分子量が20万以上であって、細孔容積の割合が96体積%以上である多孔質有機高分子である重合物αが得られる。希釈剤の使用量は、重合物αの排除限界分子量および細孔容積の割合をより一層大きくするために、原料モノマーの4.0倍以上の容積とすることが好ましい。希釈剤の使用量を原料モノマーの5.8倍以下の容積とすることで、重合物αの硬度が低くなりすぎることを防止でき、十分な機械的強度を有する重合物αが得られる。希釈剤の使用量は、より良好な機械的強度を有する重合物αを得るために、原料モノマーの5.0倍以下の容積とすることが好ましい。 By setting the volume of the diluent to be used to be 3.8 times or more of the volume of the raw material monomer, a porous organic high molecular weight having an exclusion limit molecular weight of 200,000 or more and a pore volume ratio of 96% by volume or more. A polymer α which is a molecule is obtained. The amount of the diluent used is preferably 4.0 or more times the volume of the raw material monomer in order to further increase the exclusion limit molecular weight and pore volume ratio of the polymer α. By setting the amount of the diluent used to a volume of 5.8 times or less that of the raw material monomer, it is possible to prevent the hardness of the polymer α from becoming too low, and a polymer α having sufficient mechanical strength can be obtained. The amount of the diluent used is preferably 5.0 times or less the volume of the raw material monomer in order to obtain a polymer α having better mechanical strength.

(重合開始剤)
 原料モノマーの重合に使用する重合開始剤としては、有機過酸化物、アゾ系開始剤など、公知の種々のラジカル重合開始剤を使用することができる。
 重合開始剤として用いられる有機過酸化物として、例えば、ブチルパーオキサイド系では、t-ブチルパーオキシネオデカノエート、t-ブチルパーオキシ-2-エチルヘキサノエート、t-ブチルパーオキシイソブチレート、2,5-ジメチル-2,5-ジ(ベンゾイルパーオキシ)ヘキサン、t-ブチルパーオキシアセテート、t-ブチルパーオキシベンゾエート等、アミルパーオキサイド系では、t-アミルパーオキシ-2-エチルヘキサノエート、t-アミルパーオキシ-n-オクトエート、t-アミルパーオキシアセテート、t-アミルパーオキシベンゾエート等、パーオキシカーボネート系では、t-ブチルパーオキシイソプロピルカーボネート、t-ブチルパーオキシ-2-エチルヘキシルカーボネート、t-アミルパーオキシ-2-エチルヘキシルカーボネート、ジ(2-エチルヘキシル)パーオキシジカーボネート、ジ(sec-ブチル)パーオキシジカーボネート等、ジアルキルパーオキサイド系では、ジクミルパーオキサイド、2,5-ジメチル-2,5-ジ(t-ブチルパーオキシ)へキサン、ジ-t-ブチルパーオキサイド、ジ-t-アミルパーオキサイド等、パーオキシケタール系では、1,1-ジ(t-ブチルパーオキシ)シクロヘキサン、2,2-ジ(t-ブチルパーオキシ)ブタン、エチル-3,3-ジ(t-ブチルパーオキシ)ブチレート、1,1-ジ(t-アミルパーオキシ)シクロへキサン等が例示できる。
(Polymerization initiator)
As the polymerization initiator used for the polymerization of the raw material monomers, various known radical polymerization initiators such as organic peroxides and azo initiators can be used.
Examples of the organic peroxide used as the polymerization initiator include tert-butylperoxyneodecanoate, t-butylperoxy-2-ethylhexanoate, and t-butylperoxyisobutyrate in the case of butyl peroxide. In the case of amyl peroxide systems, such as rate, 2,5-dimethyl-2,5-di (benzoylperoxy) hexane, t-butylperoxyacetate, t-butylperoxybenzoate, etc., t-amylperoxy-2-ethyl Hexanoate, t-amyl peroxy-n-octoate, t-amyl peroxyacetate, t-amyl peroxybenzoate, etc., in peroxy carbonate type, t-butyl peroxyisopropyl carbonate, t-butyl peroxy-2 -Ethylhexyl carbonate, t-amyl peroxy In dialkyl peroxides such as -2-ethylhexyl carbonate, di (2-ethylhexyl) peroxydicarbonate, di (sec-butyl) peroxydicarbonate, dicumyl peroxide, 2,5-dimethyl-2,5- In the peroxyketal type such as di (t-butylperoxy) hexane, di-t-butylperoxide, di-t-amylperoxide, etc., 1,1-di (t-butylperoxy) cyclohexane, 2, Examples include 2-di (t-butylperoxy) butane, ethyl-3,3-di (t-butylperoxy) butyrate, 1,1-di (t-amylperoxy) cyclohexane, and the like.

 重合開始剤として用いられるアゾ系開始剤としては、アゾニトリル系では、2,2’-アゾビス(4-メトキシ-2,4-ジメチルバレロニトリル)、2,2’-アゾビス(2,4-ジメチルバレロニトリル)、2,2’-アゾビス(2-メチルプロピオニトリル)、2,2’-アゾビス(2-メチルブチロニトリル)、1,1’-アゾビス(シクロヘキサン-1-カルボニトリル)等、アゾアミド系では、2,2’-アゾビス[N-(2-プロペニル)-2-メチルプロピオンアミド]、2,2’-アゾビス[N-ブチル-2-メチルプロピオンアミド]、2,2’-アゾビス[N-シクロヘキシル-2-メチルプロピオンアミド]等、他のアゾ系化合物では、2,2’-アゾビス(2-メチルプロピオンアミドオキシム)、ジメチル-2,2’-アゾビス(2-メチルプロピオネート)、4,4’-アゾビス(4-シアノバレリック酸)、2,2’-アゾビス(2,4,4-トリメチルペンタン)等が例示できる。 Examples of the azo initiator used as the polymerization initiator include 2,2′-azobis (4-methoxy-2,4-dimethylvaleronitrile) and 2,2′-azobis (2,4-dimethylvalero) in the azonitrile series. Nitrile), 2,2′-azobis (2-methylpropionitrile), 2,2′-azobis (2-methylbutyronitrile), 1,1′-azobis (cyclohexane-1-carbonitrile), etc. In the system, 2,2′-azobis [N- (2-propenyl) -2-methylpropionamide], 2,2′-azobis [N-butyl-2-methylpropionamide], 2,2′-azobis [ Other azo compounds such as N-cyclohexyl-2-methylpropionamide], 2,2′-azobis (2-methylpropionamide oxime), dimethyl- , 2'-azobis (2-methyl propionate), 4,4'-azobis (4-cyanovaleric acid), 2,2'-azobis (2,4,4-trimethylpentane) and the like.

 これらの重合開始剤は、単独で用いても良いし、2種類以上を混合して用いても良い。
 重合開始剤は、任意の量で使用でき、例えば、エポキシ基を有する単官能性モノマーと架橋性モノマーと、必要に応じて含有される他のモノマーとからなる原料モノマーの合計量100質量部に対して、0.01~15質量部、好ましくは0.05~10質量部で使用される。
These polymerization initiators may be used alone or in combination of two or more.
The polymerization initiator can be used in any amount. For example, the total amount of raw material monomers consisting of a monofunctional monomer having an epoxy group, a crosslinkable monomer, and other monomers contained as necessary is 100 parts by mass. On the other hand, it is used in an amount of 0.01 to 15 parts by mass, preferably 0.05 to 10 parts by mass.

 原料モノマーの重合方法としては、例えば、懸濁重合法、エマルジョン法、特公昭58-058026号公報および特開昭53-090991号公報に開示されている方法など、公知の方法を用いることができる。具体的には、エポキシ基を有する単官能性モノマーと、上記のモル百分率の架橋性モノマーと、必要に応じて含有される他のモノマーとからなる原料モノマーと、重合開始剤と、上記容積の希釈剤との混合液を作製し、懸濁重合法等により重合する方法などを用いることができる。 As a method for polymerizing the raw material monomer, a known method such as a suspension polymerization method, an emulsion method, a method disclosed in JP-B-58-058026 and JP-A-53-090991 can be used. . Specifically, a raw material monomer composed of a monofunctional monomer having an epoxy group, the above-described mole percentage of the crosslinkable monomer, and other monomers contained as necessary, a polymerization initiator, and a volume of the above A method of preparing a mixed solution with a diluent and polymerizing by a suspension polymerization method or the like can be used.

 本実施形態では、上記の重合を行うことにより、架橋度50mol%~85mol%の重合物αが得られる。重合物αの架橋度が50mol%以上であるので、機械的強度が十分に高い充填剤用基材が得られる。また、重合物αの架橋度が85mol%以下であるので、工程(D)において表面に天然高分子に由来する基を修飾する足掛かりとなるエポキシ基の密度を十分に確保できる。その結果、工程(D)において、天然高分子に由来する基が表面に十分に導入された充填剤用基材が得られる。 In this embodiment, a polymer α having a crosslinking degree of 50 mol% to 85 mol% is obtained by performing the above polymerization. Since the degree of crosslinking of the polymer α is 50 mol% or more, a filler base material having sufficiently high mechanical strength can be obtained. In addition, since the degree of crosslinking of the polymer α is 85 mol% or less, it is possible to sufficiently ensure the density of the epoxy groups that serve as a foothold for modifying the group derived from the natural polymer on the surface in the step (D). As a result, in the step (D), a filler base material in which a group derived from a natural polymer is sufficiently introduced on the surface is obtained.

 工程(A)において、重合により合成する重合物αは、多孔質有機高分子であり、粒子状であることが好ましい。
 粒子状の重合物αの粒径は、特に限定されるものではなく、目的とする充填剤用基材の粒径に応じて適宜決定できる。粒子状の重合物αの粒径は、以下に示す方法により調節できる。
 例えば、懸濁重合法により重合した重合物αの粒径は、重合物αを目的の目開きの篩を使用して分級する方法により調節できる。例えば、エマルジョン法により重合物αを重合する場合、重合物αの粒径は、重合時の撹拌速度等を制御する方法により調節できる。
In the step (A), the polymer α synthesized by polymerization is a porous organic polymer, and is preferably in the form of particles.
The particle size of the particulate polymer α is not particularly limited, and can be appropriately determined according to the particle size of the target filler base material. The particle size of the particulate polymer α can be adjusted by the following method.
For example, the particle diameter of the polymer α polymerized by the suspension polymerization method can be adjusted by a method of classifying the polymer α using a target sieve. For example, when polymerizing the polymer α by the emulsion method, the particle size of the polymer α can be adjusted by a method of controlling the stirring speed and the like during the polymerization.

「工程(B)」
 次に、工程(B)では、重合物αの単官能性モノマーに由来するエポキシ基を開環して多孔質有機高分子からなる担体βを得る。
 本実施形態において、重合物αの上記エポキシ基を開環するとは、重合物αのエポキシ基に水を付加し、エポキシ基を1,2-ジオール基(-CH(OH)-CH-OH)に変換することを意味する。
"Process (B)"
Next, in the step (B), the epoxy group derived from the monofunctional monomer of the polymer α is opened to obtain a carrier β made of a porous organic polymer.
In the present embodiment, ring opening of the epoxy group of the polymer α means that water is added to the epoxy group of the polymer α, and the epoxy group is converted to a 1,2-diol group (—CH (OH) —CH 2 —OH). ).

 重合物αの上記エポキシ基を開環する方法としては、特に限定されず、如何なる方法を用いてもよい。例えば、塩酸、硫酸、りん酸等を含む酸性水溶液を用いる方法、水酸化ナトリウム、水酸化カリウム等を含む塩基性水溶液を用いる方法などが挙げられる。 The method for ring-opening the epoxy group of the polymer α is not particularly limited, and any method may be used. Examples thereof include a method using an acidic aqueous solution containing hydrochloric acid, sulfuric acid, phosphoric acid and the like, and a method using a basic aqueous solution containing sodium hydroxide, potassium hydroxide and the like.

 担体βにおける1、2-ジオール基の存在は、重合物αから担体βへの質量変化によって確認および定量できる。
 具体的には、重合体αの質量を予め測定しておき、重合物αのエポキシ基を開環して担体βとした後に、担体βの質量を測定し、担体βの質量から重合体αの質量を差し引く。
このことにより、エポキシ基に付加した水の量を定量できる。
 また、赤外分光光度計により得られる担体βに含まれるエポキシ基のスペクトルから、エポキシ基の開環処理前後における当該吸収ピークの強弱を観測することで、開環処理の進行度を定性的に把握することも可能である。
The presence of 1,2-diol groups in the carrier β can be confirmed and quantified by a mass change from the polymer α to the carrier β.
Specifically, the mass of the polymer α is measured in advance, the epoxy group of the polymer α is opened to form the carrier β, the mass of the carrier β is measured, and the mass of the carrier β is determined from the mass of the carrier β. Subtract the mass of
This makes it possible to quantify the amount of water added to the epoxy group.
In addition, by observing the intensity of the absorption peak before and after the ring opening treatment of the epoxy group from the spectrum of the epoxy group contained in the carrier β obtained by an infrared spectrophotometer, the progress of the ring opening treatment can be qualitatively determined. It is also possible to grasp.

 担体βにおける排除限界分子量および細孔容積の割合は、後述する工程(C)で得られる多孔質有機高分子担体(担体γ)の排除限界分子量および細孔容積の割合に対応し、後述する工程(D)で得られる充填剤用基材(担体δ)を形成している多孔質有機高分子担体(担体γ)の排除限界分子量および細孔容積の割合に対応する。 The ratio of the exclusion limit molecular weight and the pore volume in the carrier β corresponds to the ratio of the exclusion limit molecular weight and the pore volume of the porous organic polymer support (carrier γ) obtained in the step (C) described later, and the steps described later. This corresponds to the exclusion limit molecular weight and the ratio of the pore volume of the porous organic polymer carrier (carrier γ) forming the filler base material (carrier δ) obtained in (D).

「工程(C)」
 工程(C)は、エポキシ化剤としてエピクロロヒドリンを用い、反応溶媒として2級アルコールを用いて、担体βにエポキシ基を導入し、担体γ(多孔質有機高分子担体)を得る工程である。
 担体βをエポキシ化するとは、工程(B)においてエポキシ基を開環することにより重合物αの表面に生成した1,2-ジオール基の水酸基に、エピクロロヒドリンを反応させ、担体表面にエポキシ基を導入することを意味する。
"Process (C)"
Step (C) is a step of obtaining a carrier γ (porous organic polymer carrier) by using epichlorohydrin as an epoxidizing agent and using a secondary alcohol as a reaction solvent and introducing an epoxy group into the carrier β. is there.
Epoxidation of the carrier β means that epichlorohydrin is reacted with the hydroxyl group of the 1,2-diol group generated on the surface of the polymer α by ring opening of the epoxy group in the step (B), so that the carrier surface It means introducing an epoxy group.

 担体βにエポキシ基を導入し、担体γを得る方法は、特に限定されず、如何なる方法を用いてもよい。具体的には、例えば、反応容器内に、担体βと、エピクロロヒドリンと2級アルコールとの混合液と入れて反応させた後、反応容器内に塩基性物質と2級アルコールとの混合液を加えて反応させる方法などが挙げられる。
 本実施形態では、担体βにエポキシ基を導入する反応において、反応溶媒として2級アルコールを用いるため、好ましい量のエポキシ量が導入された担体γが得られる。
The method for obtaining the carrier γ by introducing an epoxy group into the carrier β is not particularly limited, and any method may be used. Specifically, for example, after mixing the carrier β, a mixed liquid of epichlorohydrin and a secondary alcohol in a reaction vessel and reacting, mixing of the basic substance and the secondary alcohol in the reaction vessel. The method of adding a liquid and making it react is mentioned.
In this embodiment, since a secondary alcohol is used as a reaction solvent in the reaction for introducing an epoxy group into the carrier β, a carrier γ into which a preferable amount of epoxy is introduced is obtained.

 2級アルコールとしては、2-プロパノール、2-ブタノール、3-メチル-2-ブタノール、2-ペンタノール、3-ペンタノールなどが挙げられる。2級アルコールとしては、経済的に優れる2-プロパノールを用いることが好ましい。
 また、担体βにエポキシ基を導入し、担体γを得る反応において使用する塩基としては、特に制限はなく、水素化ナトリウム、カリウムt-ブトキシド、ナトリウムメトキシドなどを好適に用いることができる。
Examples of secondary alcohols include 2-propanol, 2-butanol, 3-methyl-2-butanol, 2-pentanol, and 3-pentanol. As the secondary alcohol, it is preferable to use 2-propanol which is economically excellent.
Further, the base used in the reaction for introducing the epoxy group into the carrier β to obtain the carrier γ is not particularly limited, and sodium hydride, potassium t-butoxide, sodium methoxide and the like can be suitably used.

 担体γのエポキシ基の密度は、担体γ1g当たり350μmol~650μmolであることが好ましい。担体γのエポキシ基の密度が350μmol/g以上であると、後述する工程(D)において担体γに固定化される天然高分子に由来する基の固定化量が十分に多くなり、タンパク質等の生体高分子の吸着容量が高い充填剤用基材が得られる。担体γのエポキシ基の密度は、440μmol/g以上であることが、より好ましい。一方、エポキシ基の密度が650μmol/g以下であると、後述する工程(D)における天然高分子に由来する基の固定化において、天然高分子1分子に対して複数のエポキシ基が反応することを防止できる。その結果、天然高分子に由来する基が担体に付着する形で固定化されにくく、天然高分子に由来する基のスペーサーとしての効果が発揮されやすくなり、タンパク質等の生体高分子の吸着容量が高い充填剤用基材が得られる。担体γのエポキシ基の密度は、570μmol/g以下であることが、より好ましい。 The density of the epoxy group of the carrier γ is preferably 350 μmol to 650 μmol per gram of carrier γ. When the density of the epoxy group of the carrier γ is 350 μmol / g or more, the amount of the group derived from the natural polymer immobilized on the carrier γ in the step (D) described later is sufficiently increased, and the protein or the like A base material for a filler having a high biopolymer adsorption capacity can be obtained. The density of the epoxy group of the carrier γ is more preferably 440 μmol / g or more. On the other hand, when the density of the epoxy group is 650 μmol / g or less, a plurality of epoxy groups react with one molecule of the natural polymer in immobilization of the group derived from the natural polymer in the step (D) described later. Can be prevented. As a result, it is difficult to immobilize groups derived from natural polymers in a form that adheres to the carrier, and the effect as a spacer of groups derived from natural polymers is likely to be exerted, and the adsorption capacity of biopolymers such as proteins is increased. A high filler substrate is obtained. The density of the epoxy group of the carrier γ is more preferably 570 μmol / g or less.

 担体γのエポキシ基の密度の確認方法は、特に限定されないが、例えば、以下に示す方法を用いることができる。まず、担体βにエポキシ基を導入して得られた担体γを、ジエチルアミンと反応させて担体ζとする。担体ζを適当な水溶液に分散し、酸による滴定を行なって、担体ζの有するジエチルアミノ基の量を求める。滴定値から担体ζに含有されるジエチルアミノ基のモル数を求め、これを担体γのエポキシ基のモル数として、エポキシ基の密度を算出する。 The method for confirming the density of the epoxy group of the carrier γ is not particularly limited. For example, the following method can be used. First, the carrier γ obtained by introducing an epoxy group into the carrier β is reacted with diethylamine to form a carrier ζ. The carrier ζ is dispersed in an appropriate aqueous solution, and titration with an acid is performed to determine the amount of diethylamino groups of the carrier ζ. The number of moles of diethylamino group contained in the carrier ζ is determined from the titration value, and this is used as the number of moles of the epoxy group of the carrier γ to calculate the density of the epoxy group.

「工程(D)」
 工程(D)は、担体γ(多孔質有機高分子担体)に天然高分子を固定化し、充填剤用基材(担体δ)を得る工程である。
 担体γに固定化する天然高分子としては、特に、重量平均分子量10万~100万のデキストランを用いることが好ましい。重量平均分子量10万~100万のデキストランは、水に容易に溶解するものであり、多孔質有機高分子担体への天然高分子に由来する基の導入が容易であるため、好ましい。
"Process (D)"
Step (D) is a step in which a natural polymer is immobilized on a carrier γ (porous organic polymer carrier) to obtain a filler base material (carrier δ).
As the natural polymer immobilized on the carrier γ, it is particularly preferable to use dextran having a weight average molecular weight of 100,000 to 1,000,000. Dextran having a weight average molecular weight of 100,000 to 1,000,000 is preferable because it easily dissolves in water and allows easy introduction of a group derived from a natural polymer into a porous organic polymer carrier.

 担体γに天然高分子に由来する基を固定化する方法としては、ポリマーによる粒子表面修飾方法で用いられる方法であれば、いかなる方法を用いても良い。例えば、担体γにあらかじめ導入したエポキシ基、および/または担体γ自体の表面に存在している反応性官能基(例えば、未反応のグリシジル基)と、水に溶解した天然高分子とを反応させて、固定化させる方法がある。
 これらの中でも、担体γに導入されているエポキシ基を利用して天然高分子に由来する基を固定化する方法は、エポキシ基が水に対して比較的安定であり、天然高分子との反応選択性に優れている点から、好ましい。
As a method of immobilizing a group derived from a natural polymer on the carrier γ, any method may be used as long as it is a method used in a particle surface modification method with a polymer. For example, an epoxy group previously introduced into the carrier γ and / or a reactive functional group (for example, unreacted glycidyl group) present on the surface of the carrier γ itself is reacted with a natural polymer dissolved in water. There is a way to fix it.
Among these, the method of immobilizing a group derived from a natural polymer using an epoxy group introduced into the carrier γ is relatively stable against water, and the reaction with the natural polymer It is preferable from the viewpoint of excellent selectivity.

 担体δ(充填剤用基材)における天然高分子に由来する基の固定化量は、担体γとの反応時における天然高分子の濃度などによって適宜調節できる。工程(D)では、担体δの質量に対する天然高分子に由来する基の質量の比(固定化量)を200mg/g~300mg/gとする。
 担体δに固定化された天然高分子に由来する基の固定化量は、例えば、担体γと担体δとの質量差によって確認・定量できる。具体的には、天然高分子に由来する基を固定化する前の担体γの乾燥質量を、担体δの乾燥質量から差し引き算出する。
The amount of the group derived from the natural polymer in the carrier δ (filler base material) can be appropriately adjusted depending on the concentration of the natural polymer during the reaction with the carrier γ. In step (D), the ratio of the mass of the group derived from the natural polymer to the mass of the carrier δ (immobilization amount) is 200 mg / g to 300 mg / g.
The amount of the group derived from the natural polymer immobilized on the carrier δ can be confirmed and quantified by, for example, the mass difference between the carrier γ and the carrier δ. Specifically, the dry mass of the carrier γ before immobilizing the group derived from the natural polymer is calculated by subtracting from the dry mass of the carrier δ.

 天然高分子が多糖類である場合、担体δ(充填剤用基材)の天然高分子に由来する基の固定化量の算出方法として、フェノール硫酸法を用いることができる。具体的には、担体δに対してフェノールと濃硫酸を接触させ、多糖類由来の成分の分解により発生したフルフラール誘導体の上清中の濃度を、波長490nmにおける吸光度を測定して算出する。
このことにより、多糖類に由来する基の固定化量を測定できる。
When the natural polymer is a polysaccharide, the phenol-sulfuric acid method can be used as a method for calculating the amount of the group derived from the natural polymer of the carrier δ (filler base material). Specifically, phenol and concentrated sulfuric acid are brought into contact with the carrier δ, and the concentration in the supernatant of the furfural derivative generated by decomposition of the polysaccharide-derived component is calculated by measuring the absorbance at a wavelength of 490 nm.
This makes it possible to measure the amount of immobilized groups derived from the polysaccharide.

[充填剤]
 本実施形態の充填剤は、上述した充填剤用基材に、相互作用性官能基が共有結合しているものである。
 本実施形態の充填剤は、有機高分子系の充填剤であり、クロマトグラフィーを用いてタンパク質等の生体高分子を精製する際に、カラムに充填される充填剤として好適に用いられる。
[filler]
In the filler of this embodiment, an interactive functional group is covalently bonded to the filler base material described above.
The packing material of this embodiment is an organic polymer-based packing material, and is suitably used as a packing material packed in a column when purifying a biopolymer such as protein using chromatography.

 充填剤を形成している相互作用性官能基は、タンパク質と相互作用を有する官能基である。具体的には、相互作用性官能基として、例えば、イオン交換基、疎水性基、アフィニティー官能基等があげられる。相互作用性官能基は、充填剤の用途等に応じて適宜選択できる。例えば、相互作用性官能基として、陽イオン交換基を選択した場合、充填剤は陽イオン交換樹脂となり、陰イオン交換基を選択した場合、充填剤は陰イオン交換樹脂となる。 The interactive functional group that forms the filler is a functional group that interacts with the protein. Specifically, examples of the interactive functional group include an ion exchange group, a hydrophobic group, and an affinity functional group. The interactive functional group can be appropriately selected according to the use of the filler. For example, when a cation exchange group is selected as the interactive functional group, the filler is a cation exchange resin, and when an anion exchange group is selected, the filler is an anion exchange resin.

 イオン交換基としては、例えば、弱アニオン交換基、強アニオン交換基、弱カチオン交換基、強カチオン交換基など、公知のものを用いることができる。
 疎水性基としては、例えば、ブチル基、ヘプチル基、オクチル基、フェニル基などが挙げられ、特に限定されない。
 アフィニティー官能基としては、タンパク質に親和性のある生化学的に活性な物質があげられる。例えば、ProteinA、ProteinG、抗体、レクチン類、もしくはこれらの疑似ペプチドリガンド等が挙げられる。
As an ion exchange group, well-known things, such as a weak anion exchange group, a strong anion exchange group, a weak cation exchange group, a strong cation exchange group, can be used, for example.
Examples of the hydrophobic group include, but are not particularly limited to, a butyl group, a heptyl group, an octyl group, and a phenyl group.
Examples of the affinity functional group include biochemically active substances having affinity for proteins. Examples thereof include Protein A, Protein G, antibody, lectins, and pseudo peptide ligands thereof.

 充填剤は、粒子状であることが好ましい。充填剤の平均粒径には特別の制限はなく必要に応じて選択できる。充填剤を液体クロマトグラフィー用の充填剤として用いる場合、10μm~300μmであることが好ましく、15μm~200μmであることがより好ましく、20μm~100μmであることが特に好ましい。本発明の充填剤は、目的に応じて平均粒子径を選択してよく、例えば、10~20μmや、20~40μmや、40~80μmや、80~150μmなどの範囲であって良い。充填剤の粒径が小さすぎないと、圧密化が起こり難く、高流速条件下での使用が難しくならない。また、充填剤の粒径が大きすぎないと、精製目的物の吸着容量を大きくしやすい。 The filler is preferably in the form of particles. There is no special restriction | limiting in the average particle diameter of a filler, It can select as needed. When the filler is used as a filler for liquid chromatography, it is preferably 10 μm to 300 μm, more preferably 15 μm to 200 μm, and particularly preferably 20 μm to 100 μm. The average particle size of the filler of the present invention may be selected according to the purpose, and may be, for example, in the range of 10 to 20 μm, 20 to 40 μm, 40 to 80 μm, 80 to 150 μm, and the like. If the particle size of the filler is not too small, consolidation is unlikely to occur and use under high flow rate conditions is not difficult. Moreover, if the particle size of the filler is not too large, it is easy to increase the adsorption capacity of the purification object.

上記平均粒径は、湿潤状態の体積換算平均粒径である。体積換算平均粒子径は、コールターカウンターまたは画像解析式粒度分布測定装置などで計測される。このうち、画像解析式粒度分布測定装置が好ましい、画像解析式粒度分布測定装置としては、例えば、フロー式粒子像分析装置(商品名:FPIA-3000、シスメックス株式会社製)を用いることができる。 The average particle diameter is a volume-converted average particle diameter in a wet state. The volume-converted average particle diameter is measured with a Coulter counter or an image analysis type particle size distribution measuring device. Of these, an image analysis type particle size distribution measurement device is preferable. As the image analysis type particle size distribution measurement device, for example, a flow type particle image analysis device (trade name: FPIA-3000, manufactured by Sysmex Corporation) can be used.

[充填剤の製造方法]
 次に、本実施形態の充填剤の製造方法について説明する。
 本実施形態の充填剤の製造方法は、以下に示す工程(E)を有する。
「工程(E)」
 工程(E)は、担体δ(充填剤用基材)に相互作用性官能基を導入して、担体δに相互作用性官能基が共有結合している担体ε(充填剤)を得る工程である。
[Method for producing filler]
Next, the manufacturing method of the filler of this embodiment is demonstrated.
The manufacturing method of the filler of this embodiment has the process (E) shown below.
"Process (E)"
Step (E) is a step of obtaining a carrier ε (filler) in which an interactive functional group is covalently bonded to the carrier δ by introducing an interactive functional group into the carrier δ (substrate for filler). is there.

 担体δに相互作用性官能基を導入し、相互作用性官能基が共有結合している担体εとする方法としては、特に限定されるものではなく、担体εおよび相互作用性官能基の種類に応じて決定される。担体δに導入される相互作用性官能基の導入量は、反応させる試薬の量などによって調節できる。
 相互作用性官能基の導入は、水酸基および/またはアミノ基との反応で行われることが、簡便なため、好ましい。この際、通常、担体δの天然高分子に由来する基と相互作用性官能基との反応が利用される。例えば、水酸基と相互作用性官能基との反応を利用する場合、担体γ(多孔質有機高分子担体)に由来する水酸基も、確率的に少ないとは考えられるが、利用されうる。
The method of introducing an interactive functional group into the carrier δ and making the carrier ε covalently bound to the interactive functional group is not particularly limited, and the type of the carrier ε and the interactive functional group is not limited. Will be decided accordingly. The amount of the interactive functional group introduced into the carrier δ can be adjusted by the amount of the reagent to be reacted.
The introduction of the interactive functional group is preferably performed by a reaction with a hydroxyl group and / or an amino group because it is simple. In this case, the reaction between the group derived from the natural polymer of the carrier δ and the interactive functional group is usually used. For example, when a reaction between a hydroxyl group and an interactive functional group is utilized, the hydroxyl group derived from the carrier γ (porous organic polymer carrier) is considered to be probabilistically small, but may be utilized.

 相互作用性官能基がイオン交換基である場合、例えば、以下に記載の方法を用いることができる。
 すなわち、担体δの天然高分子に由来する基における反応の基点が水酸基および/またはアミノ基である場合、ブロモエチルスルホン酸、モノクロロ酢酸、クロロヒドロキシプロパンスルホン酸、2,3-エポキシスルホン酸、1,3-プロパンスルトン、1,4-ブタンスルトン等を、担体δの水酸基および/またはアミノ基に反応させることで、天然高分子に由来する基に、陽イオン交換基が共有結合された陽イオン交換樹脂である担体εが得られる。
 また、同様に、ジエチルアミノエチルクロリド塩酸塩、グリシジルトリメチルアンモニウム塩酸塩等を、担体δの水酸基および/またはアミノ基に反応させることで、天然高分子に由来する基に、陰イオン交換基が共有結合された陰イオン交換樹脂である担体εが得られる。
When the interactive functional group is an ion exchange group, for example, the method described below can be used.
That is, when the base point of the reaction in the group derived from the natural polymer of the carrier δ is a hydroxyl group and / or an amino group, bromoethylsulfonic acid, monochloroacetic acid, chlorohydroxypropanesulfonic acid, 2,3-epoxysulfonic acid, Cation exchange in which a cation exchange group is covalently bonded to a group derived from a natural polymer by reacting 1,3-propane sultone, 1,4-butane sultone, etc. with the hydroxyl group and / or amino group of the carrier δ A carrier ε, which is a resin, is obtained.
Similarly, by reacting diethylaminoethyl chloride hydrochloride, glycidyltrimethylammonium hydrochloride, etc. with the hydroxyl group and / or amino group of the carrier δ, an anion exchange group is covalently bonded to the group derived from the natural polymer. A carrier ε, which is an anion exchange resin, is obtained.

 相互作用性官能基が疎水性基である場合、例えば、ブロモブタン、クロロブタン、オクチルクロライド、フェニルグリシジルエーテル等を、担体δの天然高分子に由来する基の水酸基および/またはアミノ基等と反応させることで、疎水性基の導入された疎水性の担体εが得られる。
 相互作用性官能基がアフィニティー官能基である場合、一般的に用いられる通常の生化学物質のリガンド固定化方法を用いて、担体δの天然高分子に由来する基にアフィニティー官能基が固定化された担体εが得られる。
When the interactive functional group is a hydrophobic group, for example, bromobutane, chlorobutane, octyl chloride, phenyl glycidyl ether, etc. are reacted with the hydroxyl group and / or amino group of the group derived from the natural polymer of the carrier δ. Thus, a hydrophobic carrier ε into which a hydrophobic group has been introduced is obtained.
When the interactive functional group is an affinity functional group, the affinity functional group is immobilized on a group derived from the natural polymer of the carrier δ using a generally used method for immobilizing a ligand of a biochemical substance. A carrier ε is obtained.

[タンパク質の精製方法]
 本実施形態のタンパク質の精製方法は、タンパク質を含む溶液を、上記の充填剤が充填されたカラムに通液する工程と、充填剤に吸着されたタンパク質を溶出させる工程とを含む。
 本実施形態のタンパク質の精製方法では、上記の充填剤を使用すること以外は、公知の方法を用いることができる。
 本実施形態のタンパク質の精製方法では、上記の充填剤が充填されたカラムを使用するため、単位体積当たりの一度に精製できる生体高分子の量が多く、高流速処理条件下で効率よく精製できる。
[Protein purification method]
The protein purification method of the present embodiment includes a step of passing a solution containing the protein through a column packed with the above-described packing material and a step of eluting the protein adsorbed on the packing material.
In the protein purification method of the present embodiment, a known method can be used except that the above filler is used.
In the protein purification method of the present embodiment, since the column packed with the above-mentioned packing is used, the amount of biopolymer that can be purified at a time per unit volume is large, and the protein can be efficiently purified under high flow rate processing conditions. .

 以下、実施例および比較例により本発明をさらに具体的に説明する。なお、本発明は、以下の実施例のみに限定されない。
[実施例1]
「工程(A)重合物α-1の合成」
 エポキシ基を有する単官能性モノマーであるグリシジルメタクリレート14.5gと、架橋性モノマーであるエチレングリコールジメタクリレート24.5gとからなる原料モノマーと、希釈剤であるクロロベンゼン195.5gと、重合開始剤である2,2’-アゾビス(2,4-ジメチルバレロニトリル)2.4gを溶解し、30分間窒素ガスをバブリングし、油相を準備した。
 原料モノマー中の架橋性モノマーのモル百分率(架橋度)は55mol%とした。また、希釈剤は177.6mlであり、原料モノマーは35.5mlであったので、希釈剤の容積は原料モノマーの5.0倍であった。
Hereinafter, the present invention will be described more specifically with reference to examples and comparative examples. In addition, this invention is not limited only to a following example.
[Example 1]
“Step (A) Synthesis of Polymer α-1”
A raw material monomer consisting of 14.5 g of glycidyl methacrylate, which is a monofunctional monomer having an epoxy group, and 24.5 g of ethylene glycol dimethacrylate, which is a crosslinkable monomer, 195.5 g of chlorobenzene, which is a diluent, and a polymerization initiator An oil phase was prepared by dissolving 2.4 g of 2,2′-azobis (2,4-dimethylvaleronitrile) and bubbling nitrogen gas for 30 minutes.
The mole percentage (crosslinking degree) of the crosslinkable monomer in the raw material monomer was 55 mol%. Moreover, since the diluent was 177.6 ml and the raw material monomer was 35.5 ml, the volume of the diluent was 5.0 times that of the raw material monomer.

 次に、油相とは別に、イオン交換水500gに、分散安定剤であるPVA-224(クラレ社製、けん化度87.0%-89.0%のポリビニルアルコール)15.0gと、塩析剤である塩化ナトリウム5.0gとを溶解させた水相を準備した。 Next, apart from the oil phase, 15.0 g of PVA-224 (manufactured by Kuraray Co., Ltd., polyvinyl alcohol having a saponification degree of 87.0% to 89.0%), 500 g of ion-exchanged water, and salting out An aqueous phase in which 5.0 g of sodium chloride as an agent was dissolved was prepared.

 水相と油相をセパラブルフラスコに移し、半月型撹拌羽を取り付けた撹拌棒で430rpmの回転速度で20分間分散させた後、反応器内を窒素で置換し、80℃で6時間反応した。その後、遠心分離により水相を除去し、得られた重合物をグラスフィルター上に移し、お湯、変性アルコール、水の順番で十分に洗浄した。洗浄後、水浴中で篩分級を行ない、減圧濾過で5分以上水分を除き、粒径25μm~75μmの水湿潤重合物を190g得た。得られた水湿潤重合物を乾燥して得た重合物α-1の質量は37gであった。 The aqueous phase and the oil phase were transferred to a separable flask and dispersed with a stirring rod equipped with a half-moon stirring blade at a rotational speed of 430 rpm for 20 minutes. . Thereafter, the aqueous phase was removed by centrifugation, and the resulting polymer was transferred onto a glass filter and washed thoroughly in the order of hot water, denatured alcohol, and water. After washing, sieving classification was performed in a water bath, and water was removed by vacuum filtration for 5 minutes or more to obtain 190 g of a water-wet polymer having a particle size of 25 μm to 75 μm. The mass of polymer α-1 obtained by drying the obtained water-wet polymer was 37 g.

「工程(B)エポキシ基の開環」
 水湿潤重合物100g(重合物α-1の乾燥重量19.5g)をセパラブルフラスコに移し、0.5mol/L硫酸水溶液500mLを加えた後、60℃に加熱し、6時間反応させた。その後、担体をグラスフィルター上に移し、水を2000mL以上用いて洗浄した。これにより、エポキシ基を開環し、1,2-ジオール基が導入された多孔質有機高分子担体(担体β-1)を得た。
 反応の完結は、ThermoScientific(登録商標)Nicolet(登録商標)iS(登録商標)10 FT-IR分光装置(商品名、サーモフィッシャー・サイエンティフィック社製)を用い、赤外分光法により、担体β-1上におけるエポキシ基吸収の消失を測定することで確認した。
"Step (B) Ring opening of epoxy group"
100 g of water-wet polymer (dry weight 19.5 g of polymer α-1) was transferred to a separable flask, 500 mL of 0.5 mol / L sulfuric acid aqueous solution was added, and the mixture was heated to 60 ° C. and reacted for 6 hours. Thereafter, the carrier was transferred onto a glass filter and washed with 2000 mL or more of water. Thus, a porous organic polymer carrier (carrier β-1) in which an epoxy group was opened and a 1,2-diol group was introduced was obtained.
The completion of the reaction was carried out by infrared spectroscopy using a Thermo Scientific (registered trademark) Nicolet (registered trademark) iS (registered trademark) 10 FT-IR spectrometer (trade name, manufactured by Thermo Fisher Scientific). This was confirmed by measuring the disappearance of epoxy group absorption on -1.

 担体β-1について、排除限界分子量および細孔容積の割合を、以下に示す方法により求めた。
 担体β-1を内径4.6mm、長さ100mmのクロマトグラフィー用ハウジングに充填し、カラムを得た。得られたカラムを使用して、溶離液を水とし、検出器に示差屈折率検出器を用いて、流速0.30mL/分(線流速108cm/時)で、各分子量のプルランを用いたサイズ排除クロマトグラフィーを行い、較正曲線を作成した。較正曲線において、高分子側のプルランの溶出が同じになるプルランの内、最小のプルランの分子量を排除限界分子量とした。その結果、実施例1の担体β-1の排除限界分子量は40万であった。
With respect to the carrier β-1, the exclusion limit molecular weight and the ratio of the pore volume were determined by the following method.
Carrier β-1 was packed in a chromatography housing having an inner diameter of 4.6 mm and a length of 100 mm to obtain a column. Using the obtained column, the eluent is water, the differential refractive index detector is used as the detector, the flow rate is 0.30 mL / min (linear flow rate: 108 cm / hr), and the size using pullulan of each molecular weight. Exclusion chromatography was performed to generate a calibration curve. In the calibration curve, the molecular weight of the smallest pullulan among the pullulans having the same elution of the pullulan on the polymer side was defined as the exclusion limit molecular weight. As a result, the exclusion limit molecular weight of the carrier β-1 of Example 1 was 400,000.

 排除限界分子量のプルランの保持時間と溶離液の流速の乗数から求められた溶離液の量を排除限界容量とした。エチレングリコールを測定した時のエチレングリコールの溶出時間と流速の乗数から浸透限界容量を求めた。排除限界容量と浸透限界容量との差を細孔容積とした。以下に示す式により、細孔容積の割合を求めた。
 細孔容積の割合(%)={(浸透限界容量)-(排除限界容量)}/{(カラム内体積)-(排除限界容量)}×100
 その結果、実施例1の担体β-1の細孔容積の割合は98体積%であった。
The amount of eluent obtained from the retention time of pullulan with the molecular weight of the exclusion limit and the multiplier of the flow rate of the eluent was defined as the exclusion limit capacity. The permeation limit capacity was determined from the elution time and flow rate multiplier of ethylene glycol when ethylene glycol was measured. The difference between the exclusion limit capacity and the penetration limit capacity was defined as the pore volume. The ratio of the pore volume was determined by the following formula.
Pore volume ratio (%) = {(permeation limit capacity) − (exclusion limit capacity)} / {(volume in column) − (exclusion limit capacity)} × 100
As a result, the ratio of the pore volume of the carrier β-1 of Example 1 was 98% by volume.

「工程(C)エポキシ基の導入」
 エポキシ基を開環した水湿潤担体(担体β-1)20gをグラスフィルター上に測りとり、2-プロパノールで十分に洗浄した。洗浄後、担体β-1をセパラブルフラスコに移し、2-プロパノール15.6gとエピクロロヒドリン10gとを加え、室温で撹拌し、さらにカリウムt-ブトキシド2.5gを2-プロパノール15.6gに溶解させた溶液を加え、30℃に加熱し、3時間撹拌した。反応終了後、担体をグラスフィルター上に移し、水、アセトン、水の順番で十分に洗浄し、水湿潤担体(担体γ-1)を得た。
“Process (C) Introduction of epoxy group”
20 g of a water-wet carrier (carrier β-1) having an epoxy group opened was weighed on a glass filter and thoroughly washed with 2-propanol. After washing, the carrier β-1 is transferred to a separable flask, 15.6 g of 2-propanol and 10 g of epichlorohydrin are added, stirred at room temperature, and 2.5 g of potassium t-butoxide is further added to 15.6 g of 2-propanol. The solution dissolved in was added, heated to 30 ° C., and stirred for 3 hours. After completion of the reaction, the carrier was transferred onto a glass filter and thoroughly washed with water, acetone and water in this order to obtain a water-wet carrier (carrier γ-1).

 得られた担体γ-1のエポキシ基の導入密度を、以下の手順により測定した。
 水湿潤担体(担体γ-1)5.0gを採取して、乾燥質量を求めた結果、0.80gであった。次に、同じ量の水湿潤担体γ(担体γ-1)を、セパラブルフラスコに測りとり、水40gに分散させ、室温で撹拌しながらジエチルアミン12gを加えた後、50℃に加熱し、4時間撹拌した。反応終了後、得られた担体をグラスフィルター上に移し、水、アセトンの順番で十分に洗浄、減圧乾燥し、乾燥担体ζ-1を得た。
The density of introduction of epoxy groups in the obtained carrier γ-1 was measured by the following procedure.
As a result of collecting 5.0 g of water-wet carrier (carrier γ-1) and determining the dry mass, it was 0.80 g. Next, the same amount of water-wet carrier γ (carrier γ-1) is weighed into a separable flask, dispersed in 40 g of water, 12 g of diethylamine is added with stirring at room temperature, heated to 50 ° C., and heated to 4 ° C. Stir for hours. After completion of the reaction, the obtained carrier was transferred onto a glass filter, thoroughly washed with water and acetone in that order, and dried under reduced pressure to obtain dry carrier ζ-1.

 得られた乾燥担体ζ-1をビーカーに移し、0.5mol/L塩化カリウム水溶液150mLに分散させ、pH4.0となった時点を中和点として0.1mol/L塩酸で滴定した。このことにより、担体ζ-1に導入されたジエチルアミンの量を算出し、以下に示す式により、担体γ-1のエポキシ基の密度を算出した。その結果、エポキシ基の密度は520μmol/gであった。
 エポキシ基の密度(μmol/g)={0.1×中和時点での塩酸容積(μl)/担体γの乾燥重量(g)}
The obtained dry carrier ζ-1 was transferred to a beaker, dispersed in 150 mL of a 0.5 mol / L aqueous potassium chloride solution, and titrated with 0.1 mol / L hydrochloric acid at the time when the pH reached 4.0. Based on this, the amount of diethylamine introduced into the carrier ζ-1 was calculated, and the density of the epoxy group of the carrier γ-1 was calculated according to the following formula. As a result, the density of the epoxy group was 520 μmol / g.
Epoxy group density (μmol / g) = {0.1 × hydrochloric acid volume at neutralization (μl) / dry weight of carrier γ (g)}

「工程(D)天然高分子の導入」
 セパラブルフラスコに天然高分子であるデキストラン200,000(和光純薬社製、平均重量分子量180,000~210,000)5.5gと、水7.2gを測りとり、溶解するまで室温で撹拌した。得られたデキストラン溶液に、水湿潤担体(担体γ-1)10g(乾燥重量0.16g)を投入し、40℃で1時間撹拌した。その後、テトラブチルアンモニウムヨージド40mgと、水素化ホウ素ナトリウム10mgと、48%水酸化ナトリウム水溶液1.7gとを加え、40℃で16時間撹拌した。反応終了後、担体をグラスフィルター上に移し、水で十分に洗浄し、水湿潤担体δ-1を得た。
“Process (D) Introduction of natural polymer”
In a separable flask, 5.5 g of natural polymer dextran 200,000 (manufactured by Wako Pure Chemical Industries, Ltd., average weight molecular weight 180,000-210,000) and 7.2 g of water are measured and stirred at room temperature until dissolved. did. To the obtained dextran solution, 10 g of water-wet carrier (carrier γ-1) (dry weight 0.16 g) was added and stirred at 40 ° C. for 1 hour. Thereafter, 40 mg of tetrabutylammonium iodide, 10 mg of sodium borohydride, and 1.7 g of a 48% aqueous sodium hydroxide solution were added, and the mixture was stirred at 40 ° C. for 16 hours. After completion of the reaction, the carrier was transferred onto a glass filter and thoroughly washed with water to obtain a water wet carrier δ-1.

 得られた担体δ-1(充填剤用基材)のデキストラン固定化量を、以下の手順で算出した。
 水湿潤担体δ-1を乾燥させた担体δ-1(充填剤用基材)をサンプル管に20mg測りとり、水0.5mLと、5%フェノール水溶液0.5mLと、濃硫酸2.5mLとを加え、1時間静置した。静置した後、20倍希釈した溶液の波長490nmにおける吸光度を、InfiniteM200PRO(商品名、テカン社製)で測定し、溶液中に含まれるフルフラール誘導体の濃度から、デキストラン導入量を算出した。その結果、デキストランの固定化量は、担体δ-1の質量を基準として、250mg/gであった。
The amount of dextran immobilized on the obtained carrier δ-1 (substrate for filler) was calculated by the following procedure.
20 mg of carrier δ-1 (substrate for filler) dried from water-wet carrier δ-1 is weighed into a sample tube, 0.5 mL of water, 0.5 mL of 5% phenol aqueous solution, 2.5 mL of concentrated sulfuric acid, And left to stand for 1 hour. After standing, the absorbance at a wavelength of 490 nm of the 20-fold diluted solution was measured with Infinite M200PRO (trade name, manufactured by Tecan), and the amount of dextran introduced was calculated from the concentration of the furfural derivative contained in the solution. As a result, the amount of dextran immobilized was 250 mg / g based on the mass of the carrier δ-1.

「工程(E)相互作用性官能基の導入」
 デキストランを導入した水湿潤担体(担体δ-1)4.0g(乾燥重量0.72g)をセパラブルフラスコに測りとり、水4.8gと、1,3-プロパンスルトン5.6gに分散させ、40℃に加熱した。40℃で撹拌しながら48%水酸化ナトリウム水溶液4.0gを加えた後、40℃で3時間撹拌した。
 反応終了後、担体をグラスフィルター上に移し、水、アセトン、水の順番で洗浄を行なった。洗浄後、担体をビーカーに移し、水200mLを加え、十分に分散させた後、45分間静置した。上清を除去した後、グラスフィルター上で担体を水で洗浄し、陽イオン交換基であるスルホ基の導入された水湿潤状態の充填剤1(担体ε-1)を得た。
"Step (E) Introduction of interactive functional group"
4.0 g (dry weight 0.72 g) of a water-wet carrier into which dextran was introduced (carrier δ-1) was weighed into a separable flask and dispersed in 4.8 g of water and 5.6 g of 1,3-propane sultone. Heated to 40 ° C. While stirring at 40 ° C., 4.0 g of a 48% aqueous sodium hydroxide solution was added, followed by stirring at 40 ° C. for 3 hours.
After completion of the reaction, the carrier was transferred onto a glass filter and washed with water, acetone and water in this order. After washing, the carrier was transferred to a beaker, 200 mL of water was added and sufficiently dispersed, and then allowed to stand for 45 minutes. After removing the supernatant, the carrier was washed with water on a glass filter to obtain water- filled filler 1 (carrier ε-1) into which a sulfo group as a cation exchange group was introduced.

 得られた充填剤1を内径4.0mm、長さ50mmのPEEK製クロマトグラフ用ハウジング((株)巴製作所製)に充填した。充填剤1は、スラリー調製液として0.3mol/L芒硝水溶液を用い、流速4.2mL/分の条件で20分かけて充填した。得られたカラムを用いて、以下に示す方法により、吸着・溶出試験を行い、IgG(イミノグロブリンG)の吸着容量を測定した。
 測定したIgGの吸着容量を表1に示す。吸着したIgGは、溶出ステップの溶出液を分取することで回収した。
The obtained filler 1 was packed into a PEEK chromatographic housing (manufactured by Sakai Seisakusho Co., Ltd.) having an inner diameter of 4.0 mm and a length of 50 mm. Filler 1 was filled using a 0.3 mol / L sodium sulfate aqueous solution as a slurry preparation solution at a flow rate of 4.2 mL / min over 20 minutes. Using the obtained column, the adsorption / elution test was performed by the method shown below, and the adsorption capacity of IgG (iminoglobulin G) was measured.
Table 1 shows the measured IgG adsorption capacity. The adsorbed IgG was recovered by fractionating the eluate from the elution step.

「陽イオン交換基の導入された充填剤のIgGの吸着容量の測定」<吸着ステップ>
・免疫グロブリンG(IgG)濃度:0.9mg/mL~1.1mg/mL・吸着緩衝液:20mMクエン酸緩衝液(pH5.3)
・送液速度:1000cm/時(流速2.1mL/分)
“Measurement of IgG Adsorption Capacity of Packing Material Introduced with Cation Exchange Group” <Adsorption Step>
Immunoglobulin G (IgG) concentration: 0.9 mg / mL to 1.1 mg / mL Adsorption buffer: 20 mM citrate buffer (pH 5.3)
・ Liquid feeding speed: 1000 cm / hr (flow rate 2.1 mL / min)

<洗浄ステップ>
・洗浄緩衝液:20mMクエン酸緩衝液(pH5.3)
・送液量:10CV
<溶出ステップ>
・溶出液:20mMクエン酸緩衝液(pH5.3)と1.0M NaClの混合液・送液量:10CV
(CVはカラムボリュームの略であり、上記実験では、0.63mLに相当する。)
<Washing step>
Wash buffer: 20 mM citrate buffer (pH 5.3)
・ Liquid feeding amount: 10 CV
<Elution step>
-Eluent: 20 mM citrate buffer solution (pH 5.3) and 1.0 M NaCl-Feed volume: 10 CV
(CV is an abbreviation for column volume and corresponds to 0.63 mL in the above experiment.)

 吸着ステップで、溶液に含まれるIgGの10%がカラムから漏出した時点において、充填剤に吸着されたIgGの容量をIgGの吸着容量と定義した。吸着容量は、下記の式(1)により算出した。
 吸着容量(mg/mL-ゲル)=(10%漏出時点での送液量(mL)×IgG濃度(mg/mL))/ゲル容積(mL-ゲル)     …(1)
 式(1)において、10%漏出時点での送液量とは、カラム未装着時にIgG溶液を送液した際に検出器で観測された紫外線(UV)吸収値を100%漏出とし、その吸収値の10%のUV吸収値が観測された時点での送液開始からの送液量の合計である。ゲル容積とは、充填剤の容積であり、カラム内の充填剤をメスシリンダーに移し、十分に沈降した時点での容積の値である。
In the adsorption step, when 10% of IgG contained in the solution leaked from the column, the capacity of IgG adsorbed on the packing material was defined as the IgG adsorption capacity. The adsorption capacity was calculated by the following equation (1).
Adsorption capacity (mg / mL-gel) = (Amount of liquid delivered at the time of 10% leakage (mL) × IgG concentration (mg / mL)) / Gel volume (mL-gel) (1)
In equation (1), the amount of liquid delivered at the time of 10% leakage is the absorption of the ultraviolet (UV) absorption observed by the detector when the IgG solution was delivered when the column was not installed, and the absorption. This is the total amount of liquid delivered from the beginning of liquid delivery when a 10% UV absorption value was observed. The gel volume is the volume of the packing material, and is the value of the volume when the packing material in the column is transferred to the measuring cylinder and sufficiently settled.

 吸着容量を測定したカラムを装置に設置した状態で、1000cm/時(流速2.1mL/分)の流速での圧力損失を測定した。次に、充填剤の入っていない空カラムを設置し、送液システムの1000cm/時での圧力損失を測定した。二つの圧力損失の値から、1000cm/時という高流速条件下でのカラムの圧力損失を算出した。その結果を表1に示す。
 吸着容量を測定する実験において背圧が上昇する現象は見られず、得られたカラムは、高流速条件下でも支障なく使用できることが示された。このことから、充填剤1が十分な強度を有することが分かった。
The pressure loss at a flow rate of 1000 cm / hour (flow rate 2.1 mL / min) was measured with the column having the adsorption capacity measured installed in the apparatus. Next, an empty column containing no filler was installed, and the pressure loss at 1000 cm / hour of the liquid feeding system was measured. From the two pressure loss values, the pressure loss of the column under a high flow rate condition of 1000 cm / hour was calculated. The results are shown in Table 1.
In the experiment for measuring the adsorption capacity, no increase in the back pressure was observed, indicating that the obtained column can be used without any trouble even under high flow rate conditions. From this, it was found that the filler 1 has sufficient strength.

[実施例2]
「工程(E)相互作用性官能基の導入」
 実施例1と同様にして得たデキストランを導入した水湿潤担体(担体δ-1)を4.0g(乾燥重量0.72g)をセパラブルフラスコに測りとり、5mol/L水酸化ナトリウム水溶液5.0gに分散させ、室温で30分間撹拌した。ジエチルアミノエチルクロリド塩酸塩3.0gを溶解した水5.0gを添加し、70℃まで昇温し、2時間撹拌した。
 反応終了後、担体をグラスフィルター上に移し、水で洗浄を行なった。洗浄後、担体をビーカーに移し、水200mLを加え、十分に分散させた後、45分間静置した。上清を除去した後、グラスフィルター上で担体を水で洗浄し、陰イオン交換基であるジエチルアミノ基の導入された充填剤2(担体ε-2)を得た。
[Example 2]
"Step (E) Introduction of interactive functional group"
4.0 g (dry weight 0.72 g) of a water-wet carrier (carrier δ-1) introduced with dextran obtained in the same manner as in Example 1 was weighed into a separable flask, and 5 mol / L aqueous sodium hydroxide solution was added. The mixture was dispersed in 0 g and stirred at room temperature for 30 minutes. 5.0 g of water in which 3.0 g of diethylaminoethyl chloride hydrochloride was dissolved was added, the temperature was raised to 70 ° C., and the mixture was stirred for 2 hours.
After completion of the reaction, the carrier was transferred onto a glass filter and washed with water. After washing, the carrier was transferred to a beaker, 200 mL of water was added and sufficiently dispersed, and then allowed to stand for 45 minutes. After removing the supernatant, the carrier was washed with water on a glass filter to obtain a filler 2 (carrier ε-2) into which a diethylamino group as an anion exchange group was introduced.

 得られた充填剤2を内径4.0mm、長さ50mmのPEEK製クロマトグラフ用ハウジングに充填し、以下に示す方法により、吸着・溶出試験を行い、BSA(牛血清アルブミン)の吸着容量を測定した。BSAの吸着容量は、実施例1におけるIgGの吸着容量の求め方と同様にして求めた。
 実施例2におけるBSAの吸着容量を表1に示す。吸着したBSAは、溶出ステップでの溶出液を分取することで回収した。
The obtained packing material 2 is filled into a chromatographic housing made of PEEK having an inner diameter of 4.0 mm and a length of 50 mm, and an adsorption / elution test is performed by the following method to measure the adsorption capacity of BSA (bovine serum albumin). did. The adsorption capacity of BSA was determined in the same manner as the method for determining the adsorption capacity of IgG in Example 1.
Table 1 shows the adsorption capacity of BSA in Example 2. The adsorbed BSA was recovered by separating the eluate from the elution step.

「陰イオン交換基の導入された充填剤のBSAの吸着容量の測定」<吸着ステップ>
・牛血清アルブミン(BSA)濃度:0.9mg/mL~1.1mg/mL・吸着緩衝液:50mMトリス塩酸塩緩衝液(pH8.5)・送液速度:1000cm/時(流速2.1mL/分)
“Measurement of BSA adsorption capacity of fillers with anion exchange groups” <Adsorption step>
Bovine serum albumin (BSA) concentration: 0.9 mg / mL to 1.1 mg / mL Adsorption buffer: 50 mM Tris hydrochloride buffer (pH 8.5) Feed rate: 1000 cm / hour (flow rate 2.1 mL / Min)

<洗浄ステップ>
・洗浄緩衝液:50mMトリス塩酸塩緩衝液(pH8.5)・送液量:10CV
<溶出ステップ>
・溶出液:50mMトリス塩酸塩緩衝液(pH8.5)と1.0M NaClの混合液・送液量:10CV
<Washing step>
Washing buffer: 50 mM Tris hydrochloride buffer (pH 8.5) Feeding volume: 10 CV
<Elution step>
-Eluent: 50 mM Tris hydrochloride buffer solution (pH 8.5) and 1.0 M NaCl-Feed volume: 10 CV

 また、実施例1と同様にして、高流速条件下でのカラムの圧力損失を算出した。その結果を表1に示す。
 また、実施例2においても、吸着容量を測定する実験において背圧が上昇する現象は見られず、充填剤2が十分な強度を有することが分かった。
Further, in the same manner as in Example 1, the pressure loss of the column under the high flow rate condition was calculated. The results are shown in Table 1.
Moreover, also in Example 2, the phenomenon which a back pressure raises was not seen in the experiment which measures adsorption capacity, and it turned out that the filler 2 has sufficient intensity | strength.

[実施例3]
「工程(E)相互作用性官能基の導入」
 実施例1と同様にして得たデキストランを導入した水湿潤担体(担体δ-1)を4.0g(乾燥重量0.72g)セパラブルフラスコに測りとり、水8.0g、グリシジルトリメチルアンモニウム塩酸塩4.5gを添加し、40℃で8時間撹拌した。
 反応終了後、担体をグラスフィルター上に移し、水で洗浄を行なった。洗浄後、担体をビーカーに移し、水200mLを加え、十分に分散させた後、45分間静置した。上清を除去した後、グラスフィルター上で担体を水で洗浄し、陰イオン交換基としてのトリメチルアンモニウム基の導入された充填剤3(担体ε-3)を得た。
[Example 3]
"Step (E) Introduction of interactive functional group"
4.0 g (dry weight 0.72 g) of a water-wet carrier (carrier δ-1) introduced with dextran obtained in the same manner as in Example 1 was weighed into a separable flask, 8.0 g of water, and glycidyltrimethylammonium hydrochloride. 4.5g was added and it stirred at 40 degreeC for 8 hours.
After completion of the reaction, the carrier was transferred onto a glass filter and washed with water. After washing, the carrier was transferred to a beaker, 200 mL of water was added and sufficiently dispersed, and then allowed to stand for 45 minutes. After removing the supernatant, the carrier was washed with water on a glass filter to obtain a filler 3 (carrier ε-3) into which a trimethylammonium group as an anion exchange group was introduced.

 得られた充填剤3を用いて実施例2と同様にして、BSAの吸着容量を測定した。その結果を表1に示す。
 また、実施例1と同様にして、高流速条件下でのカラムの圧力損失を算出した。その結果を表1に示す。
 また、実施例3においても、吸着容量を測定する実験において背圧が上昇する現象は見られず、充填剤3が十分な強度を有することが分かった。
Using the obtained filler 3, the adsorption capacity of BSA was measured in the same manner as in Example 2. The results are shown in Table 1.
Further, in the same manner as in Example 1, the pressure loss of the column under the high flow rate condition was calculated. The results are shown in Table 1.
Moreover, also in Example 3, the phenomenon which a back pressure raises was not seen in the experiment which measures adsorption capacity, and it turned out that the filler 3 has sufficient intensity | strength.

[実施例4]
 エポキシ基を導入する工程において、エピクロロヒドリンの使用量を4.0gとし、カリウム-t-ブトキシドの使用量を1.0gとし、30℃に加熱してからの撹拌時間を6時間としたこと以外は、実施例1と同様にして充填剤4(担体ε-4)を得た。
 充填剤4を製造する途中の工程で得た担体γ-4のエポキシ基の導入密度と、担体δ-4(充填剤用基材)のデキストラン固定化量を、実施例1と同様にして求めた。その結果を表1に示す。
[Example 4]
In the step of introducing an epoxy group, the amount of epichlorohydrin used was 4.0 g, the amount of potassium t-butoxide was 1.0 g, and the stirring time after heating to 30 ° C. was 6 hours. Except for this, a filler 4 (carrier ε-4) was obtained in the same manner as in Example 1.
The introduction density of the epoxy group of the carrier γ-4 obtained in the course of manufacturing the filler 4 and the amount of dextran immobilized on the carrier δ-4 (substrate for filler) were obtained in the same manner as in Example 1. It was. The results are shown in Table 1.

 充填剤4を用いて実施例1と同様にして、IgGの吸着容量を測定した。その結果を表1に示す。
 また、実施例1と同様にして、高流速条件下でのカラムの圧力損失を算出した。その結果を表1に示す。
 また、実施例4においても、吸着容量を測定する実験において背圧が上昇する現象は見られず、充填剤4が十分な強度を有することが分かった。
Using the filler 4, the IgG adsorption capacity was measured in the same manner as in Example 1. The results are shown in Table 1.
Further, in the same manner as in Example 1, the pressure loss of the column under the high flow rate condition was calculated. The results are shown in Table 1.
Moreover, also in Example 4, the phenomenon which a back pressure raises was not seen in the experiment which measures adsorption capacity, and it turned out that the filler 4 has sufficient intensity | strength.

[実施例5]
 エポキシ基を導入する工程において、エピクロロヒドリンの使用量を20.0gとし、カリウム-t-ブトキシドの使用量を5.0gとしたこと以外は、実施例1と同様にして、充填剤5(担体ε-5)を得た。
 充填剤5を製造する途中の工程で得た担体γ-5のエポキシ基の導入密度と、担体δ-5(充填剤用基材)のデキストラン固定化量を、実施例1と同様にして求めた。その結果を表1に示す。
[Example 5]
In the step of introducing an epoxy group, filler 5 was used in the same manner as in Example 1 except that the amount of epichlorohydrin used was 20.0 g and the amount of potassium tert-butoxide was 5.0 g. (Carrier ε-5) was obtained.
The introduction density of the epoxy group of the carrier γ-5 obtained in the course of manufacturing the filler 5 and the amount of dextran immobilized on the carrier δ-5 (substrate for filler) were determined in the same manner as in Example 1. It was. The results are shown in Table 1.

 充填剤5を用いて実施例1と同様にして、IgGの吸着容量を測定した。その結果を表1に示す。
 また、実施例1と同様にして、高流速条件下でのカラムの圧力損失を算出した。その結果を表1に示す。
 また、実施例5においても、吸着容量を測定する実験において背圧が上昇する現象は見られず、充填剤5が十分な強度を有することが分かった。
The adsorption capacity of IgG was measured in the same manner as in Example 1 using the filler 5. The results are shown in Table 1.
Further, in the same manner as in Example 1, the pressure loss of the column under the high flow rate condition was calculated. The results are shown in Table 1.
Moreover, also in Example 5, the phenomenon which raises back pressure was not seen in the experiment which measures adsorption capacity, and it turned out that the filler 5 has sufficient intensity | strength.

[実施例6]
 重合物αを合成する工程において、グリシジルメタクリレートの使用量を10.9gとし、エチレングリコールジメタクリレートの使用量を28.2gとしたこと以外は、実施例1と同様にして、充填剤6(担体ε-6)を得た。
 充填剤6を製造する途中の工程で得た担体β-6について、排除限界分子量および細孔容積の割合を、実施例1と同様にして求めた。その結果を表1に示す。
 また、担体γ-6のエポキシ基の導入密度と、担体δ-6(充填剤用基材)のデキストラン固定化量を、実施例1と同様にして求めた。その結果を表1に示す。
[Example 6]
In the step of synthesizing polymer α, filler 6 (carrier) was the same as in Example 1 except that the amount of glycidyl methacrylate used was 10.9 g and the amount of ethylene glycol dimethacrylate was 28.2 g. ε-6) was obtained.
With respect to the carrier β-6 obtained in the process of producing the filler 6, the exclusion limit molecular weight and the ratio of the pore volume were determined in the same manner as in Example 1. The results are shown in Table 1.
Further, the introduction density of the epoxy group of the carrier γ-6 and the amount of dextran immobilized on the carrier δ-6 (substrate for filler) were determined in the same manner as in Example 1. The results are shown in Table 1.

 充填剤6を用いて実施例1と同様にして、IgGの吸着容量を測定した。その結果を表1に示す。
 また、実施例1と同様にして、高流速条件下でのカラムの圧力損失を算出した。その結果を表1に示す。
 また、実施例6においても、吸着容量を測定する実験において背圧が上昇する現象は見られず、充填剤6が十分な強度を有することが分かった。
Using the filler 6, the IgG adsorption capacity was measured in the same manner as in Example 1. The results are shown in Table 1.
Further, in the same manner as in Example 1, the pressure loss of the column under the high flow rate condition was calculated. The results are shown in Table 1.
Moreover, also in Example 6, the phenomenon which a back pressure raises was not seen in the experiment which measures adsorption capacity, and it turned out that the filler 6 has sufficient intensity | strength.

[比較例1]
 重合物αを合成する工程において、希釈剤であるクロロベンゼンの使用量を40.6gとしたこと以外は、実施例1と同様にして、比較例1の充填剤を得た。比較例1における希釈剤の容積は原料モノマーの1.0倍であった。
 比較例1の充填剤を製造する途中の工程で得た担体β(比1)について、排除限界分子量および細孔容積の割合を、実施例1と同様にして求めた。その結果を表1に示す。
 また、比較例1の充填剤を製造する途中の工程で得た担体γ(比1)のエポキシ基の導入密度と、担体δ(比1)(充填剤用基材)のデキストラン固定化量を、実施例1と同様にして求めた。その結果を表1に示す。
[Comparative Example 1]
In the step of synthesizing the polymer α, the filler of Comparative Example 1 was obtained in the same manner as in Example 1 except that the amount of chlorobenzene used as the diluent was 40.6 g. The volume of the diluent in Comparative Example 1 was 1.0 times that of the raw material monomer.
For the carrier β (ratio 1) obtained in the process of producing the filler of Comparative Example 1, the exclusion limit molecular weight and the ratio of the pore volume were determined in the same manner as in Example 1. The results are shown in Table 1.
In addition, the introduction density of the epoxy group of the carrier γ (ratio 1) obtained in the course of manufacturing the filler of Comparative Example 1 and the amount of dextran immobilized on the carrier δ (ratio 1) (substrate for filler) This was determined in the same manner as in Example 1. The results are shown in Table 1.

 比較例1の充填剤を用いて実施例1と同様にして、IgGの吸着容量を測定した。その結果を表1に示す。
 また、実施例1と同様にして、高流速条件下でのカラムの圧力損失を算出した。その結果を表1に示す。
 また、比較例1においても、吸着容量を測定する実験において背圧が上昇する現象は見られず、比較例1の充填剤が十分な強度を有することが分かった。
The adsorption capacity of IgG was measured in the same manner as in Example 1 using the filler of Comparative Example 1. The results are shown in Table 1.
Further, in the same manner as in Example 1, the pressure loss of the column under the high flow rate condition was calculated. The results are shown in Table 1.
Moreover, also in the comparative example 1, the phenomenon which a back pressure raises in the experiment which measures adsorption capacity was not seen, but it turned out that the filler of the comparative example 1 has sufficient intensity | strength.

[比較例2]
 エポキシ基を導入する工程において、2-プロパノールに代えて、ジメチルスルホキシドを用いたこと以外は、実施例1と同様にして、比較例2の充填剤を得た。
 比較例2の充填剤を製造する途中の工程で得た担体γ(比2)のエポキシ基の導入密度と、担体δ(比2)(充填剤用基材)のデキストラン固定化量を、実施例1と同様にして求めた。その結果を表1に示す。
[Comparative Example 2]
A filler of Comparative Example 2 was obtained in the same manner as in Example 1 except that dimethyl sulfoxide was used instead of 2-propanol in the step of introducing an epoxy group.
The introduction density of the epoxy group of the carrier γ (ratio 2) obtained in the process of manufacturing the filler of Comparative Example 2 and the amount of dextran immobilized on the carrier δ (ratio 2) (substrate for filler) were carried out. Determined in the same manner as in Example 1. The results are shown in Table 1.

 比較例2の充填剤を用いて実施例1と同様にして、IgGの吸着容量を測定した。その結果を表1に示す。
 また、実施例1と同様にして、高流速条件下でのカラムの圧力損失を算出した。その結果を表1に示す。
 また、比較例2においても、吸着容量を測定する実験において背圧が上昇する現象は見られず、比較例2の充填剤が十分な強度を有することが分かった。
The adsorption capacity of IgG was measured in the same manner as in Example 1 using the filler of Comparative Example 2. The results are shown in Table 1.
Further, in the same manner as in Example 1, the pressure loss of the column under the high flow rate condition was calculated. The results are shown in Table 1.
Moreover, also in the comparative example 2, the phenomenon which a back pressure raises was not seen in the experiment which measures adsorption capacity, and it turned out that the filler of the comparative example 2 has sufficient intensity | strength.

[比較例3]
 エポキシ基を導入する工程において、2-プロパノールに代えて、エタノールを用いたこと以外は、実施例1と同様にして、比較例3の充填剤を得た。
 比較例3の充填剤を製造する途中の工程で得た担体γ(比3)のエポキシ基の導入密度と、担体δ(比3)(充填剤用基材)のデキストラン固定化量を、実施例1と同様にして求めた。その結果を表1に示す。
[Comparative Example 3]
In the step of introducing an epoxy group, a filler of Comparative Example 3 was obtained in the same manner as in Example 1 except that ethanol was used instead of 2-propanol.
The introduction density of the epoxy group of the carrier γ (ratio 3) obtained in the process of manufacturing the filler of Comparative Example 3 and the amount of dextran immobilized on the carrier δ (ratio 3) (substrate for filler) were carried out. Determined in the same manner as in Example 1. The results are shown in Table 1.

 比較例3の充填剤を用いて実施例1と同様にして、IgGの吸着容量を測定した。その結果を表1に示す。
 また、実施例1と同様にして、高流速条件下でのカラムの圧力損失を算出した。その結果を表1に示す。
 また、比較例3においても、吸着容量を測定する実験において背圧が上昇する現象は見られず、比較例3の充填剤が十分な強度を有することが分かった。
The adsorption capacity of IgG was measured in the same manner as in Example 1 using the filler of Comparative Example 3. The results are shown in Table 1.
Further, in the same manner as in Example 1, the pressure loss of the column under the high flow rate condition was calculated. The results are shown in Table 1.
Also in Comparative Example 3, the phenomenon of increasing the back pressure was not observed in the experiment for measuring the adsorption capacity, and it was found that the filler of Comparative Example 3 had sufficient strength.

[比較例4]
 天然高分子を導入する工程において、デキストラン200,000を溶解する水の使用量を14.4gとしたこと以外は、実施例1と同様にして、比較例4の充填剤を得た。
 比較例4の充填剤を製造する途中の工程で得た担体δ(比4)(充填剤用基材)のデキストラン固定化量を、実施例1と同様にして求めた。その結果を表1に示す。
[Comparative Example 4]
In the step of introducing the natural polymer, the filler of Comparative Example 4 was obtained in the same manner as in Example 1 except that the amount of water used for dissolving dextran 200,000 was 14.4 g.
The amount of dextran immobilized on the carrier δ (ratio 4) (base material for filler) obtained in the course of manufacturing the filler of Comparative Example 4 was determined in the same manner as in Example 1. The results are shown in Table 1.

 比較例4の充填剤を用いて実施例1と同様にして、IgGの吸着容量を測定した。その結果を表1に示す。
 また、実施例1と同様にして、高流速条件下でのカラムの圧力損失を算出した。その結果を表1に示す。
 また、比較例4においても、吸着容量を測定する実験において背圧が上昇する現象は見られず、比較例4の充填剤が十分な強度を有することが分かった。
The adsorption capacity of IgG was measured in the same manner as in Example 1 using the filler of Comparative Example 4. The results are shown in Table 1.
Further, in the same manner as in Example 1, the pressure loss of the column under the high flow rate condition was calculated. The results are shown in Table 1.
Moreover, also in the comparative example 4, the phenomenon which raises back pressure was not seen in the experiment which measures adsorption capacity, and it turned out that the filler of the comparative example 4 has sufficient intensity | strength.

[比較例5]
 重合物αを合成する工程において、グリシジルメタクリレートの使用量を27.8gとし、エチレングリコールジメタクリレートの使用量を11.3gとしたこと以外は、実施例1と同様にして、重合物αを合成した。その結果、油相が固化せず、重合物αは得られなかった。
[Comparative Example 5]
In the step of synthesizing the polymer α, the polymer α is synthesized in the same manner as in Example 1 except that the amount of glycidyl methacrylate used is 27.8 g and the amount of ethylene glycol dimethacrylate is 11.3 g. did. As a result, the oil phase did not solidify and the polymer α was not obtained.

[比較例6]
 重合物αを合成する工程において、グリシジルメタクリレートの使用量を18.3gとし、エチレングリコールジメタクリレートの使用量を20.8gとしたこと以外は、実施例1と同様にして、比較例6の充填剤を得た。
 比較例6の充填剤を製造する途中の工程で得た担体β(比6)について、排除限界分子量および細孔容積の割合を、実施例1と同様にして求めた。その結果を表1に示す。
 また、担体γ(比6)のエポキシ基の導入密度と、担体δ(比6)(充填剤用基材)のデキストラン固定化量を、実施例1と同様にして求めた。その結果を表1に示す。
[Comparative Example 6]
In the step of synthesizing the polymer α, the filling of Comparative Example 6 was performed in the same manner as in Example 1 except that the amount of glycidyl methacrylate used was 18.3 g and the amount of ethylene glycol dimethacrylate was 20.8 g. An agent was obtained.
For the carrier β (ratio 6) obtained in the process of producing the filler of Comparative Example 6, the exclusion limit molecular weight and the ratio of the pore volume were determined in the same manner as in Example 1. The results are shown in Table 1.
Further, the introduction density of the epoxy group of the carrier γ (ratio 6) and the amount of dextran immobilized on the carrier δ (ratio 6) (substrate for filler) were determined in the same manner as in Example 1. The results are shown in Table 1.

 比較例6の充填剤を用いて実施例1と同様にして、IgGの吸着容量を測定した。しかし、カラム背圧が上昇して、サンプルの送液ができなかった。また、カラム背圧が上昇したため、圧力損失を算出することができなかった。このことから、比較例6の充填剤は、強度が不十分であることがわかる。 The IgG adsorption capacity was measured in the same manner as in Example 1 using the filler of Comparative Example 6. However, the column back pressure increased and the sample could not be fed. In addition, the pressure loss could not be calculated because the column back pressure increased. From this, it can be seen that the filler of Comparative Example 6 has insufficient strength.

Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001

 表1に、実施例1~6、比較例1~6の原料モノマー中の架橋性モノマーのモル百分率(架橋度)、希釈剤の原料モノマーに対する容積比、多孔質有機高分子担体の排除限界分子量、細孔容積の割合、充填剤用基材の質量に対する天然高分子に由来する基の質量の比(デキストラン固定化量)、充填剤の吸着容量および圧力損失を示す。表1の吸着容量の欄に記載の(IgG)はIgGの吸着容量であることを意味し、(BSA)はBSAの吸着容量であることを意味する。 Table 1 shows the molar percentage (crosslinking degree) of the crosslinkable monomer in the raw material monomers of Examples 1 to 6 and Comparative Examples 1 to 6, the volume ratio of the diluent to the raw material monomer, and the exclusion limit molecular weight of the porous organic polymer carrier. The ratio of the pore volume, the ratio of the mass of the group derived from the natural polymer to the mass of the filler substrate (dextran immobilization amount), the adsorption capacity of the filler and the pressure loss are shown. (IgG) described in the column of adsorption capacity in Table 1 means that it is the adsorption capacity of IgG, and (BSA) means that it is the adsorption capacity of BSA.

 表1に示すように、実施例1~6の充填剤は、比較例1~4と比較して、吸着容量が高かった。
 比較例1では、希釈剤容積比が小さいため、充填剤用基材の細孔容積の割合が小さく、デキストラン固定化量が低くなった。その結果、比較例1の充填剤は、吸着容量が低くなった。
As shown in Table 1, the fillers of Examples 1 to 6 had a higher adsorption capacity than Comparative Examples 1 to 4.
In Comparative Example 1, since the diluent volume ratio was small, the ratio of the pore volume of the base material for filler was small, and the amount of dextran immobilized was low. As a result, the adsorption capacity of the filler of Comparative Example 1 was low.

 比較例2では、2-プロパノールに代えてジメチルスルホキシドを用いたため、充填剤用基材のデキストラン固定化量が大きくなった。その結果、比較例2の充填剤は、吸着容量が低くなった。
 比較例3では、2-プロパノールに代えてエタノールを用いたため、充填剤用基材のデキストラン固定化量が低くなった。その結果、比較例3の充填剤は、吸着容量が低くなった。
 比較例4では、充填剤用基材のデキストラン固定化量が低いため、充填剤の吸着容量が低くなった。
In Comparative Example 2, since dimethyl sulfoxide was used instead of 2-propanol, the amount of dextran immobilized on the base material for filler increased. As a result, the adsorption capacity of the filler of Comparative Example 2 was low.
In Comparative Example 3, since ethanol was used instead of 2-propanol, the amount of dextran immobilized on the filler base material was low. As a result, the adsorption capacity of the filler of Comparative Example 3 was low.
In Comparative Example 4, since the amount of dextran immobilized on the filler base material was low, the adsorption capacity of the filler was low.

 比較例5では、架橋度が不足したため、重合物(多孔質有機高分子)が得られなかった。
 比較例6では、充填剤用基材の架橋度が不足しているため、充填剤の吸着容量が低くなった。
In Comparative Example 5, a polymer (porous organic polymer) could not be obtained because the degree of crosslinking was insufficient.
In Comparative Example 6, since the degree of cross-linking of the filler base material was insufficient, the adsorption capacity of the filler was low.

 本発明の充填剤は、タンパク質に対し高流速処理条件下で高い吸着容量を示すため、生体高分子の精製において好適に用いられる。本発明は、十分な機械的強度を有し、かつ生体高分子の吸着容量が高い充填剤および充填剤の製造方法を提供する。 Since the filler of the present invention exhibits a high adsorption capacity for proteins under high flow rate treatment conditions, it is preferably used in the purification of biopolymers. The present invention provides a filler having a sufficient mechanical strength and a high biopolymer adsorption capacity, and a method for producing the filler.

Claims (11)

 多孔質有機高分子担体の表面に、天然高分子が固定化された、充填剤用基材であり、
 前記多孔質有機高分子担体は、
       架橋度が50mol%~85mol%であり、
       排除限界分子量が20万~80万であり、
       細孔容積の割合が96体積%~99体積%であり、
 前記充填剤用基材の質量に対する天然高分子に由来する基の質量の比が、200mg/g~300mg/gである充填剤用基材。
It is a base material for filler in which a natural polymer is immobilized on the surface of a porous organic polymer carrier,
The porous organic polymer carrier is
The degree of crosslinking is from 50 mol% to 85 mol%,
Exclusion limit molecular weight is 200,000 to 800,000,
The proportion of the pore volume is 96 vol% to 99 vol%,
A filler base material having a ratio of a mass of a group derived from a natural polymer to a mass of the filler base material of 200 mg / g to 300 mg / g.
 前記天然高分子が、多糖類である、請求項1に記載の充填剤用基材。 The base material for filler according to claim 1, wherein the natural polymer is a polysaccharide.  前記多糖類が、デキストランである、請求項2に記載の充填剤用基材。 The base material for filler according to claim 2, wherein the polysaccharide is dextran.  請求項1~請求項3のいずれか一項に記載の充填剤用基材に、相互作用性官能基が共有結合している、充填剤。 A filler in which an interactive functional group is covalently bonded to the filler base material according to any one of claims 1 to 3.  前記相互作用性官能基が、陽イオン交換基である、請求項4に記載の充填剤。 The filler according to claim 4, wherein the interactive functional group is a cation exchange group.  前記相互作用性官能基が、陰イオン交換基である、請求項4に記載の充填剤。 The filler according to claim 4, wherein the interactive functional group is an anion exchange group.  請求項1~請求項3のいずれか一項に記載の充填剤用基材の製造方法であり、
 エポキシ基を有する単官能性モノマーと架橋性モノマーとを含む原料モノマーを、希釈剤および重合開始剤の存在下で重合して重合物αを得る工程であって、
 前記原料モノマー中の前記架橋性モノマー濃度を50mol%~85mol%とし、前記希釈剤を前記原料モノマーの3.8倍~5.8倍の容積で使用する工程(A)と、
 前記重合物αの単官能性モノマーに由来するエポキシ基を開環して、多孔質有機高分子からなる担体βを得る工程(B)と、
 エピクロロヒドリンと2級アルコールとを用いて前記担体βにエポキシ基を導入し、担体γを得る工程(C)と、
 前記担体γに天然高分子を固定化して担体δを得る工程であって、前記担体δの質量に対する天然高分子に由来する基の質量の比を200mg/g~300mg/gとする工程(D)とを有する、充填剤用基材の製造方法。
A method for producing a filler base material according to any one of claims 1 to 3,
A step of polymerizing a raw material monomer containing a monofunctional monomer having an epoxy group and a crosslinkable monomer in the presence of a diluent and a polymerization initiator to obtain a polymer α,
A step (A) in which the concentration of the crosslinkable monomer in the raw material monomer is 50 mol% to 85 mol%, and the diluent is used in a volume of 3.8 times to 5.8 times the raw material monomer;
Opening the epoxy group derived from the monofunctional monomer of the polymer α to obtain a carrier β made of a porous organic polymer (B);
A step (C) of obtaining a carrier γ by introducing an epoxy group into the carrier β using epichlorohydrin and a secondary alcohol;
A step of obtaining a carrier δ by immobilizing a natural polymer on the carrier γ, wherein the ratio of the mass of the group derived from the natural polymer to the mass of the carrier δ is 200 mg / g to 300 mg / g (D The manufacturing method of the base material for fillers which has these.
 前記エポキシ基を有する単官能性モノマーがグリシジルメタクリレートであり、
 前記架橋性モノマーがエチレングリコールジメタクリレートであり、
 前記希釈剤がクロロベンゼンであり、
 前記2級アルコールが2-プロパノールである、請求項7に記載の充填剤用基材の製造方法。
The monofunctional monomer having an epoxy group is glycidyl methacrylate,
The crosslinkable monomer is ethylene glycol dimethacrylate;
The diluent is chlorobenzene,
The method for producing a filler base material according to claim 7, wherein the secondary alcohol is 2-propanol.
 前記天然高分子が、重量平均分子量10万~100万のデキストランである、請求項7または請求項8に記載の充填剤用基材の製造方法。 The method for producing a filler base material according to claim 7 or 8, wherein the natural polymer is dextran having a weight average molecular weight of 100,000 to 1,000,000.  前記担体γのエポキシ基の密度が、担体γ1g当たり350μmol~650μmolである、請求項7~請求項9のいずれか一項に記載の充填剤用基材の製造方法。 10. The method for producing a filler base material according to claim 7, wherein the density of the epoxy group of the carrier γ is 350 μmol to 650 μmol per gram of carrier γ.  タンパク質を含む溶液を、請求項4~請求項6のいずれか一項に記載の充填剤が充填されたカラムに通液する工程と、
 前記充填剤に吸着されたタンパク質を溶出させる工程とを含むタンパク質の精製方法。
Passing a protein-containing solution through a column filled with the packing material according to any one of claims 4 to 6,
And a step of eluting the protein adsorbed on the filler.
PCT/JP2018/045660 2018-03-29 2018-12-12 Base material for filler, manufacturing method of base material for filler, filler, and protein purification method Ceased WO2019187377A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018063418 2018-03-29
JP2018-063418 2018-03-29

Publications (1)

Publication Number Publication Date
WO2019187377A1 true WO2019187377A1 (en) 2019-10-03

Family

ID=68058701

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2018/045660 Ceased WO2019187377A1 (en) 2018-03-29 2018-12-12 Base material for filler, manufacturing method of base material for filler, filler, and protein purification method

Country Status (1)

Country Link
WO (1) WO2019187377A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4206243A4 (en) * 2021-06-28 2024-11-13 Resonac Corporation Filler, method for producing same, and column for size exclusion chromatography
WO2025126602A1 (en) * 2023-12-13 2025-06-19 Jsr株式会社 Production method for chromatographic carrier

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6317906A (en) * 1986-07-10 1988-01-25 Tokyo Organ Chem Ind Ltd Production of porous granular copolymer
JPH03136A (en) * 1989-05-26 1991-01-07 Fuji Spinning Co Ltd Production of chitosan chelate forming molded body
JP2008232764A (en) * 2007-03-19 2008-10-02 Tosoh Corp New filler for packed bed and its use
JP2016011835A (en) * 2012-03-30 2016-01-21 三菱化学株式会社 Liquid chromatography packing, liquid chromatography column and liquid chromatography apparatus
JP2017083363A (en) * 2015-10-30 2017-05-18 Jsr株式会社 Carrier for affinity chromatography, chromatography column, purification method, and target material purified by the method

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6317906A (en) * 1986-07-10 1988-01-25 Tokyo Organ Chem Ind Ltd Production of porous granular copolymer
JPH03136A (en) * 1989-05-26 1991-01-07 Fuji Spinning Co Ltd Production of chitosan chelate forming molded body
JP2008232764A (en) * 2007-03-19 2008-10-02 Tosoh Corp New filler for packed bed and its use
JP2016011835A (en) * 2012-03-30 2016-01-21 三菱化学株式会社 Liquid chromatography packing, liquid chromatography column and liquid chromatography apparatus
JP2017083363A (en) * 2015-10-30 2017-05-18 Jsr株式会社 Carrier for affinity chromatography, chromatography column, purification method, and target material purified by the method

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4206243A4 (en) * 2021-06-28 2024-11-13 Resonac Corporation Filler, method for producing same, and column for size exclusion chromatography
WO2025126602A1 (en) * 2023-12-13 2025-06-19 Jsr株式会社 Production method for chromatographic carrier

Similar Documents

Publication Publication Date Title
EP1889857B1 (en) Novel packing material with excellent hydrophilicity and process for producing the same
KR102017649B1 (en) A novel chromatographic media based on allylamine and its derivative for protein purification
JP5250985B2 (en) New filler for packed bed and its use
JP5715953B2 (en) Temperature-responsive polymer particles in protein separation treatment
WO2017026453A1 (en) Separating agent and liquid-chromatography column
CN108883394B (en) Chromatographic matrix
He et al. Investigation of imprinting parameters and their recognition nature for quinine-molecularly imprinted polymers
JP2005510609A5 (en)
WO2009104323A1 (en) Polymer capable of adsorbing acidic water-soluble target substance, and method for production of the polymer
JP2016006410A (en) Chromatography carrier and protein purification method using the same
JP5280604B2 (en) Post-modification of porous support
JP2005510593A5 (en)
US20220176273A1 (en) Packing material for size exclusion chromatography and method for producing the same
WO2019187377A1 (en) Base material for filler, manufacturing method of base material for filler, filler, and protein purification method
Leber et al. 2, 4, 6‐trichlorophenyl acrylate emulsion‐templated porous polymers (PolyHIPEs). Morphology and reactivity studies
WO2015129622A1 (en) Filler for liquid chromatography and liquid chromatography column
JP6737579B2 (en) Affinity chromatography carrier, chromatography column, purification method, and target substance purified by the method
WO2019110318A1 (en) Porous materials, method for producing same and uses thereof
Arrua et al. Preparation of macroporous monoliths based on epoxy-bearing hydrophilic terpolymers and applied for affinity separations
WO2016143673A1 (en) Filler for liquid chromatography
WO2023054507A1 (en) Method for producing stationary phase for column chromatography
JPH0788366A (en) Method for producing separating agent
JP7186338B1 (en) Packing material, manufacturing method thereof, and column for size exclusion chromatography
JP4746402B2 (en) Packing agent for liquid chromatography and method for measuring hemoglobin
WO2023276550A1 (en) Filler and manufacturing method therefor, and column for size exclusion chromatography

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18912906

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18912906

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP